<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK32534" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK32534/" /><meta name="ncbi_pagename" content="KCNQ2-Related Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>KCNQ2-Related Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="KCNQ2-Related Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/09/27" /><meta name="citation_author" content="Francesco Miceli" /><meta name="citation_author" content="Maria Virginia Soldovieri" /><meta name="citation_author" content="Nishtha Joshi" /><meta name="citation_author" content="Sarah Weckhuysen" /><meta name="citation_author" content="Edward Cooper" /><meta name="citation_author" content="Maurizio Taglialatela" /><meta name="citation_pmid" content="20437616" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK32534/" /><meta name="citation_keywords" content="KCNQ2-Related Benign Familial Neonatal Epilepsy (BFNE)" /><meta name="citation_keywords" content="KCNQ2-Related Neonatal Epileptic Encephalopathy (NEE)" /><meta name="citation_keywords" content="Potassium voltage-gated channel subfamily KQT member 2" /><meta name="citation_keywords" content="KCNQ2" /><meta name="citation_keywords" content="KCNQ2-Related Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="KCNQ2-Related Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Francesco Miceli" /><meta name="DC.Contributor" content="Maria Virginia Soldovieri" /><meta name="DC.Contributor" content="Nishtha Joshi" /><meta name="DC.Contributor" content="Sarah Weckhuysen" /><meta name="DC.Contributor" content="Edward Cooper" /><meta name="DC.Contributor" content="Maurizio Taglialatela" /><meta name="DC.Date" content="2018/09/27" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK32534/" /><meta name="description" content="KCNQ2-related disorders represent a continuum of overlapping neonatal epileptic phenotypes caused by a heterozygous pathogenic variant in KCNQ2. The clinical features of KCNQ2-related disorders range from KCNQ2-related benign familial neonatal epilepsy (KCNQ2-BFNE) at the mild end to KCNQ2-related neonatal epileptic encephalopathy (KCNQ2-NEE) at the severe end." /><meta name="og:title" content="KCNQ2-Related Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="KCNQ2-related disorders represent a continuum of overlapping neonatal epileptic phenotypes caused by a heterozygous pathogenic variant in KCNQ2. The clinical features of KCNQ2-related disorders range from KCNQ2-related benign familial neonatal epilepsy (KCNQ2-BFNE) at the mild end to KCNQ2-related neonatal epileptic encephalopathy (KCNQ2-NEE) at the severe end." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK32534/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/bfns/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK32534/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CDCE0E040237100000000082502D2.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK32534_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK32534_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kcnk9-is/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kcnq3-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK32534_"><span class="title" itemprop="name"><i>KCNQ2</i>-Related Disorders</span></h1><p class="contrib-group"><span itemprop="author">Francesco Miceli</span>, PhD, <span itemprop="author">Maria Virginia Soldovieri</span>, PhD, <span itemprop="author">Nishtha Joshi</span>, BDS, MPH, <span itemprop="author">Sarah Weckhuysen</span>, MD, PhD, <span itemprop="author">Edward Cooper</span>, MD, PhD, and <span itemprop="author">Maurizio Taglialatela</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK32534_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK32534_ai__"><div class="contrib half_rhythm"><span itemprop="author">Francesco Miceli</span>, PhD<div class="affiliation small">Division of Pharmacology<br />Department of Neuroscience<br />University of Naples Federico II<br />Naples, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.aninu@ilecimrf" class="oemail">ti.aninu@ilecimrf</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Maria Virginia Soldovieri</span>, PhD<div class="affiliation small">Department of Medicine and Health Science<br />University of Molise<br />Campobasso, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.lominu@ireivodlos.ainigrivairam" class="oemail">ti.lominu@ireivodlos.ainigrivairam</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Nishtha Joshi</span>, BDS, MPH<div class="affiliation small">Department of Neurology<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@ihsoj.ahthsin" class="oemail">ude.mcb@ihsoj.ahthsin</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sarah Weckhuysen</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />University Hospital Antwerp<br />Neurogenetics Group<br />Department of Molecular Genetics, VIB<br />Antwerp, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@kcewharas" class="oemail">moc.liamtoh@kcewharas</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Edward Cooper</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@1cce" class="oemail">ude.mcb@1cce</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Maurizio Taglialatela</span>, MD, PhD<div class="affiliation small">Department of Medicine and Health Science<br />University of Molise<br />Campobasso, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.aninu@lailgatm" class="oemail">ti.aninu@lailgatm</a><span style="unicode-bidi: bidi-override; direction: ltr;">; </span><a href="mailto:dev@null" data-email="ti.lominu@aletalailgat.m" class="oemail">ti.lominu@aletalailgat.m</a><div></div></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 27, 2010</span>; Last Revision: <span itemprop="dateModified">September 27, 2018</span>.</p><p><em>Estimated reading time: 32 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="bfns.Summary" itemprop="description"><h2 id="_bfns_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>KCNQ2</i>-related disorders represent a continuum of overlapping neonatal epileptic phenotypes caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KCNQ2</i>. The clinical features of <i>KCNQ2</i>-related disorders range from <i>KCNQ2</i>-related benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (KCNQ2-BFNE) at the mild end to <i>KCNQ2</i>-related neonatal epileptic encephalopathy (KCNQ2-NEE) at the severe end.</p><ul><li class="half_rhythm"><div>KCNQ2-BFNE is characterized by a wide spectrum of seizure types (tonic or apneic episodes, focal clonic activity, or autonomic changes) that start in otherwise healthy infants between the second and eighth day of life and spontaneously disappear between the first and the sixth to 12th month of life. Motor activity may be confined to one body part, migrate to other body regions, or generalize. Seizures are generally brief, lasting one to two minutes. Rarely, KCNQ2-BFNE may evolve into status epilepticus. About 10%-15% of individuals with BFNE develop epileptic seizures later in life.</div></li><li class="half_rhythm"><div>KCNQ2-NEE is characterized by multiple daily seizures beginning in the first week of life that are mostly tonic, with associated focal motor and autonomic features. Seizures generally cease between ages nine months and four years. At onset, EEG shows a burst-suppression pattern or multifocal epileptiform activity; early brain MRI can show basal ganglia and thalamic hyperintensities that later resolve. Moderate to severe developmental impairment is present.</div></li></ul></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis relies on the presence of characteristic clinical findings and <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>KCNQ2</i> (also known as <i>Kv7.2</i>), which codes for voltage-gated potassium channel subunits.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i></p><ul><li class="half_rhythm"><div>KCNQ2-BFNE. The majority of children can be kept seizure-free by using phenobarbital (20 mg/kg as loading dose and 5 mg/kg/day as maintenance dose). In some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, seizures require other antiepileptic drugs (AEDs).</div></li><li class="half_rhythm"><div>KCNQ2-NEE. Children have multiple daily seizures resistant at onset to phenobarbital and other common old- and new-generation AEDs, alone or in combination. Sodium channel blockers like phenytoin (PHT) or carbamazepine (CBZ) were shown to control seizures in several patients and should be considered first-line treatment.</div></li></ul><p><i>Surveillance:</i></p><ul><li class="half_rhythm"><div>KCNQ2-BFNE. EEG at age three, 12, and 24 months is appropriate. At 24 months EEG should be normal.</div></li><li class="half_rhythm"><div>KCNQ<i>2</i>-NEE. EEG monitoring is highly recommended, although specific guidelines are not available.</div></li></ul></div><div><h4 class="inline">Genetic counseling.</h4><p><i>KCNQ2</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals diagnosed with KCNQ2-BFNE have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; however, a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may have KCNQ2-BFNE as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Almost all individuals with KCNQ2-NEE have a <i>de novo</i> pathogenic variant. Each child of an individual with a <i>KCNQ2</i>-related disorder has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant in the family is known.</p></div></div><div id="bfns.GeneReview_Scope"><h2 id="_bfns_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="bfns.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32534/table/bfns.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bfns.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bfns.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNQ2</i>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_bfns.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE)</div></li><li class="half_rhythm"><div>Neonatal epileptic encephalopathy (NEE)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#bfns.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="bfns.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#bfns.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="bfns.Diagnosis"><h2 id="_bfns_Diagnosis_">Diagnosis</h2><p><i>KCNQ2</i>-related disorders represent a continuum of overlapping neonatal epileptic phenotypes ranging from <i>KCNQ2</i>-related benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE) at the mild end to <i>KCNQ2</i>-related neonatal epileptic encephalopathy (NEE) at the severe end.</p><div id="bfns.Testing"><h3>Testing</h3><p>In KCNQ2-BFNE, all laboratory tests are normal, including brain CT and MRI.</p><p>In KCNQ2-NEE, brain MRI frequently shows bilateral or asymmetric hyperintensities in the basal ganglia, and sometimes in the thalamus; these may resolve over time. Other common findings are small frontal lobes with increased adjacent extra-axial spaces, thin corpus callosum, and decreased posterior white matter volume.</p></div><div id="bfns.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of a <i>KCNQ2</i>-related disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a characteristic history and examination when a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified in <i>KCNQ2</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK32534/table/bfns.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figbfnsTmoleculargenetictestingusedin" rid-ob="figobbfnsTmoleculargenetictestingusedin">Table 1</a>).</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>KCNQ2</i> is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>KCNQ2</i> and other genes of interest (see <a href="#bfns.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>KCNQ2</i>) fails to confirm a diagnosis in an individual with features of a <i>KCNQ2</i>-related disorder. Such testing may provide an unexpected or previously unconsidered diagnosis, such as mutation in another gene that causes a similar clinical presentation.</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="bfns.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>KCNQ2</i>-Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32534/table/bfns.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bfns.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bfns.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_bfns.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_bfns.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_bfns.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNQ2</i></td><td headers="hd_h_bfns.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_bfns.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>60%-80% in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> KCNQ2-BFNE&#x000a0;<sup>4</sup></div></li><li class="half_rhythm"><div>Nearly 100% of the <i>KCNQ2</i> variants responsible for NEE are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> detectable by direct <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</div></li></ul>
</td></tr><tr><td headers="hd_h_bfns.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a><sup>5</sup></td><td headers="hd_h_bfns.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>20%-40% of KCNQ2-BFNE&#x000a0;<sup>6</sup></div></li><li class="half_rhythm"><div>No deletions/duplications described in individuals with KCNQ2-NEE</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="bfns.TF.1.1"><p class="no_margin">See <a href="/books/NBK32534/#bfns.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="bfns.TF.1.2"><p class="no_margin">See <a href="#bfns.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="bfns.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="bfns.TF.1.4"><p class="no_margin">In 60% and 80% of probands with BFNE, a likely-<a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KCNQ2</i> can be found (17/30 [<a class="bk_pop" href="#bfns.REF.singh.2003.2726">Singh et al 2003</a>]; 27/33 [<a class="bk_pop" href="#bfns.REF.grinton.2015.1071">Grinton et al 2015</a>]). In 10/80 [<a class="bk_pop" href="#bfns.REF.weckhuysen.2012.15">Weckhuysen et al 2012</a>] or 11/84 [<a class="bk_pop" href="#bfns.REF.weckhuysen.2013.1697">Weckhuysen et al 2013</a>] of individuals with unexplained neonatal or early-infantile seizures and psychomotor retardation with a negative family history, a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>KCNQ2</i> variant can be detected (~10% overall). This figure is higher if probands with neonatal-onset EE only are included (3/12 [<a class="bk_pop" href="#bfns.REF.saitsu.2012.298">Saitsu et al 2012</a>]) or if individuals with epilepsy onset in the first three months are included (16/71 [<a class="bk_pop" href="#bfns.REF.milh.2013.80">Milh et al 2013</a>]). It is lower (5%) if individuals with later-onset infantile seizures (West syndrome) are also included (12/239 [<a class="bk_pop" href="#bfns.REF.kato.2013.1282">Kato et al 2013</a>]).</p></div></dd><dt>5. </dt><dd><div id="bfns.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="bfns.TF.1.6"><p class="no_margin">In BFNE, one large <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> and several large deletions involving <i>KCNQ2</i>, some also involving <a href="#bfns.Suggestive_Findings">contiguous genes</a>, have been reported [<a class="bk_pop" href="#bfns.REF.singh.1998.25">Singh et al 1998</a>, <a class="bk_pop" href="#bfns.REF.heron.2007.791">Heron et al 2007</a>, <a class="bk_pop" href="#bfns.REF.kurahashi.2009.1214">Kurahashi et al 2009</a>, <a class="bk_pop" href="#bfns.REF.soldovieri.2014.356">Soldovieri et al 2014</a>, <a class="bk_pop" href="#bfns.REF.grinton.2015.1071">Grinton et al 2015</a>]. Deletions or duplications of <i>KCNQ2</i> were found in 4/21 individuals with BFNE, benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal-infantile seizures (BFNIS), or <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> neonatal seizures (i.e., a single occurrence in a family) in whom no coding or <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> pathogenic variants had been identified in either <i>KCNQ2</i> or <i>KCNQ3</i>. Among families with BFNE, the detection rate was 4/9 cases [<a class="bk_pop" href="#bfns.REF.heron.2007.791">Heron et al 2007</a>]. In the RIKEE database (<a href="http://www.rikee.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www<wbr style="display:inline-block"></wbr>​.rikee.org</a>), which contains information about <i>KCNQ2</i> variants that have been published in the medical literature through December 2015, nine submicrosopic deletions are reported among 119 reported unrelated BFNE cases/pedigrees (7.6%). For information about <i>KCNQ3</i> see <a href="#bfns.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="bfns.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>KCNQ2</i>-related disorders <b>should be suspected</b> in individuals with the following two presentations.</p><p><b><i>KCNQ2</i>-related benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (KCNQ2-BFNE)</b> [<a class="bk_pop" href="#bfns.REF.berg.2010.676">Berg et al 2010</a>] is characterized by the following general features:</p><ul><li class="half_rhythm"><div>Seizures starting between two and eight days after term birth and spontaneously disappearing between the first and the sixth to the 12th month of life in an otherwise healthy infant</div></li><li class="half_rhythm"><div>Normal physical examination and laboratory tests prior to, between, and after seizures</div></li><li class="half_rhythm"><div>No specific EEG criteria</div></li></ul><p>Seizure features include the following [<a class="bk_pop" href="#bfns.REF.international_league_against_epilepsy.1989.389">International League Against Epilepsy 1989</a>, <a class="bk_pop" href="#bfns.REF.ronen.1993.1355">Ronen et al 1993</a>, <a class="bk_pop" href="#bfns.REF.engel.2001.796">Engel 2001</a>]:</p><ul><li class="half_rhythm"><div>A wide spectrum of seizure types is seen, encompassing tonic (often focal) or apneic episodes, focal clonic activity, or autonomic changes.</div></li><li class="half_rhythm"><div>Ictal motor activity may be confined to one limb, migrate to other body regions, or generalize.</div></li><li class="half_rhythm"><div>Seizures are generally brief, lasting one to two minutes. However, they may be very frequent and cause considerable concern, especially if the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is the first family member being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li><li class="half_rhythm"><div>Infants are well between seizures, feed normally, and show normal social and motor developmental progression.</div></li><li class="half_rhythm"><div>Rarely, seizures occur in a crescendo of activity, with a possible evolution into status epilepticus.</div></li><li class="half_rhythm"><div>Interictal EEG may be normal, rarely showing a pattern of "<i>theta pointu alternant.</i>"</div></li><li class="half_rhythm"><div>Ictal EEG shows focal discharges with possible secondary generalization.</div></li></ul><p><b><i>KCNQ2</i>-related neonatal epileptic encephalopathy (KCNQ2-NEE)</b> is characterized by the following:</p><ul><li class="half_rhythm"><div>Seizure onset occurs in the first week of life.</div></li><li class="half_rhythm"><div>Seizures are mostly tonic, with associated focal motor and autonomic features (similar to KCNQ2-BFNE).</div></li><li class="half_rhythm"><div>Multiple daily seizures occur at onset, with frequent seizures in the first few months to the first year of life.</div></li><li class="half_rhythm"><div>Cessation of seizures generally occurs between age nine months and four years.</div></li><li class="half_rhythm"><div>Encephalopathy is present from birth and persists during and after the period when seizures are uncontrolled. Subsequently, developmental impairment is moderate in about one third of individuals, and severe to profound in the remaining two thirds.</div></li><li class="half_rhythm"><div>EEGs in the first week of life show a burst suppression pattern or multifocal epileptiform activity.</div></li><li class="half_rhythm"><div>Over time, seizure frequency diminishes, and interictal epileptiform discharges become less frequent. EEGs after seizure freedom is achieved are normal or show mild slow background activity.</div></li></ul></div><div id="bfns.Contiguous_Gene_Rearrangements"><h3>Contiguous Gene Rearrangements</h3><p>In two individuals with BFNE in whom <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions in <i>KCNQ2</i> were identified, concomitant deletions of the adjacent <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>CHRNA4</i>, encoding the cholinergic receptor, nicotinic alpha 4 subunit, have been described [<a class="bk_pop" href="#bfns.REF.kurahashi.2009.1214">Kurahashi et al 2009</a>]. The clinical course in these individuals was that of typical BFNE, and neither had the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <a href="/books/n/gene/adnfle/">autosomal dominant nocturnal frontal lobe epilepsy</a> (ADNFLE), another focal epilepsy caused by pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> (but not <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>) variants in <i>CHRNA4</i>.</p><p>Individuals with chromosomal microdeletions at 20q13.33 were shown to have epileptic seizures mostly beginning within the neonatal period and disappearing by age four months, similar to epilepsy phenotypes of BFNE; developmental outcome was good in patients with <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> restricted to <i>CHRNA4</i>, <i>KCNQ2</i>, and <i>COL20A1</i>, whereas delay in developmental milestones and behavioral problems such as autistic spectrum disorder was observed in patients with a wider range of deletion [<a class="bk_pop" href="#bfns.REF.traylor.2010.e12462">Traylor et al 2010</a>, <a class="bk_pop" href="#bfns.REF.pascual.2013.35">Pascual et al 2013</a>, <a class="bk_pop" href="#bfns.REF.okumura.2015.165">Okumura et al 2015</a>].</p></div></div><div id="bfns.Clinical_Characteristics"><h2 id="_bfns_Clinical_Characteristics_">Clinical Characteristics</h2><div id="bfns.Clinical_Description"><h3>Clinical Description</h3><p><i>KCNQ2</i>-related disorders include a continuum of overlapping neonatal-onset epileptic phenotypes ranging from benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy at the mild end to epileptic encephalopathy at the severe end.</p><div id="bfns.KCNQ2Related_Benign_Familial_Neonat"><h4><i>KCNQ2</i>-Related Benign Familial Neonatal Epilepsy (KCNQ2-BFNE)</h4><p>Seizures in neonates with KCNQ2-BFNE start between age two and eight days of life and spontaneously disappear between the first and the sixth to 12th month of life in otherwise healthy infants, in a context of normal neuropsychological development and EEG recordings.</p><p>Historically, the percentage of children with KCNQ2-BFNE who experience subsequent (i.e., post-infantile) focal or generalized seizures has been thought to be in the 10%-15% range [<a class="bk_pop" href="#bfns.REF.ronen.1993.1355">Ronen et al 1993</a>, <a class="bk_pop" href="#bfns.REF.plouin.2012">Plouin &#x00026; Neubauer 2012</a>]. However, in a recent comprehensive follow-up study in which 140 individuals (27 families) were followed for up to 25 years, post-infantile seizures recurred in 40 (31%). Although the characteristics of such recurrences were varied, three common patterns emerged: simple febrile seizures (n=18; 13%), seizures in childhood (n=14; 10%), and seizures primarily in adolescence or adulthood (n=19; 14%). A few children with KCNQ2-BFNE have been noted to develop an EEG trait characterized by centrotemporal spikes (CTS) and sharp waves or benign epilepsy with centrotemporal spikes (BECT) [<a class="bk_pop" href="#bfns.REF.coppola.2003.131">Coppola et al 2003</a>, <a class="bk_pop" href="#bfns.REF.ishii.2012.122">Ishii et al 2012</a>].</p></div><div id="bfns.KCNQ2Related_Neonatal_Epileptic_Enc"><h4><i>KCNQ2</i>-Related Neonatal Epileptic Encephalopathy (KCNQ2-NEE)</h4><p>In rare instances, <i>KCNQ2</i> pathogenic variants have been observed in families with KCNQ2-BFNE including one or more individuals who developed a therapy-resistant epileptic encephalopathy shortly after birth and a variable degree of intellectual disability by age four to five years [<a class="bk_pop" href="#bfns.REF.alfonso.1997.249">Alfonso et al 1997</a>, <a class="bk_pop" href="#bfns.REF.dedek.2003.21">Dedek et al 2003</a>, <a class="bk_pop" href="#bfns.REF.borgatti.2004.57">Borgatti et al 2004</a>]. In all these cases, the poor developmental outcome was not associated with neuroradiologic abnormalities suggestive of prenatal or perinatal damage. In light of more recent findings (see following), the BFNE <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of some family members could be explained by genetic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a>.</p><p>More recently, a distinct neonatal epileptic encephalopathy linked to <i>KCNQ2</i> pathogenic variants has been reported in eight of 80 probands with neonatal epileptic encephalopathy, early-onset refractory seizures, and intellectual disability of unknown origin [<a class="bk_pop" href="#bfns.REF.weckhuysen.2012.15">Weckhuysen et al 2012</a>]. In most of these <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, developmental delay was associated with axial hypotonia and/or spastic quadriplegia. Most patients are severely delayed in reaching developmental milestones, are nonverbal, or only use a few words or short sentences. Some are unable to sit independently, have poor eye contact, and show little interest in their surroundings. Seizures as well as early MRI brain abnormalities (mainly occurring in the basal ganglia and thalamus) generally resolved by age three years. After this first report, additional studies have identified novel <i>KCNQ2</i> variants in individuals with neonatal epileptic encephalopathy [<a class="bk_pop" href="#bfns.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#bfns.REF.carvill.2013.825">Carvill et al 2013</a>, <a class="bk_pop" href="#bfns.REF.milh.2013.80">Milh et al 2013</a>, <a class="bk_pop" href="#bfns.REF.weckhuysen.2013.1697">Weckhuysen et al 2013</a>, <a class="bk_pop" href="#bfns.REF.allen.2014.e99">Allen et al 2014</a>, <a class="bk_pop" href="#bfns.REF.dalen_meursvan_der_schoor.2014.136">Dalen Meurs-van der Schoor et al 2014</a>, <a class="bk_pop" href="#bfns.REF.milh.2015.2314">Milh et al 2015</a>, <a class="bk_pop" href="#bfns.REF.pisano.2015.685">Pisano et al 2015</a>].</p><p>At the most severe end of the spectrum, some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have symptoms that fall within the clinical description of Ohtahara syndrome [<a class="bk_pop" href="#bfns.REF.saitsu.2012.298">Saitsu et al 2012</a>, <a class="bk_pop" href="#bfns.REF.kato.2013.1282">Kato et al 2013</a>, <a class="bk_pop" href="#bfns.REF.martin.2014.3200">Martin et al 2014</a>], an early-onset age-related epileptic encephalopathy characterized by typical suppression-burst EEG pattern within the first months of life and poor outcome in terms of psychomotor development and seizure control (see <a href="#bfns.Differential_Diagnosis">Differential Diagnosis</a>).</p></div><div id="bfns.Other_Rarer_Phenotypes"><h4>Other Rarer Phenotypes</h4><p><b>Myokymia.</b> In two families with a <i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (p.Arg207Trp) neonatal seizures were later followed by peripheral nerve hyperexcitability (myokymia) [<a class="bk_pop" href="#bfns.REF.dedek.2001.12272">Dedek et al 2001</a>] or myoclonus-like dyskinesia [<a class="bk_pop" href="#bfns.REF.blumkin.2012.356">Blumkin et al 2012</a>]. Myokymia in the absence of neonatal seizures was described in one individual with a <i>KCNQ2</i> pathogenic variant who represented a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) [<a class="bk_pop" href="#bfns.REF.wuttke.2007.2045">Wuttke et al 2007</a>].</p><p><b>Benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile seizures (BFIS)</b> is characterized by later onset of seizures (age ~6 months). A <i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been detected in a Chinese family with BFIS [<a class="bk_pop" href="#bfns.REF.zhou.2006.691">Zhou et al 2006</a>]. In this case, the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> also developed paroxysmal myokymic episodes.</p><p><b>Infantile spasms.</b> Three children with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who did not have neonatal seizures but onset of infantile spasms at a few months of age have been reported [<a class="bk_pop" href="#bfns.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#bfns.REF.carvill.2013.825">Carvill et al 2013</a>, <a class="bk_pop" href="#bfns.REF.weckhuysen.2013.1697">Weckhuysen et al 2013</a>]. They all had concomitant intellectual disability.</p></div></div><div id="bfns.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Given the rarity of <i>KCNQ2</i>-related disorders and the inter- and intrafamilial phenotypic variability, <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are difficult to establish. Nonetheless, attempts are under way to correlate the <i>KCNQ2</i> variant type with the clinical course and severity of the disease.</p><p>In general, <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> caused by the loss of function of a single <i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> (<a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, splice, or <a class="def" href="/books/n/gene/glossary/def-item/frameshift-variant/">frameshift variant</a>) is the most common cause of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> KCNQ2-BFNE. Pathogenic variants so far identified in KCNQ2-NEE are all <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, and are thought to exert more severe functional defects on potassium current function [<a class="bk_pop" href="#bfns.REF.miceli.2013.4386">Miceli et al 2013</a>, <a class="bk_pop" href="#bfns.REF.orhan.2014.382">Orhan et al 2014</a>].</p><p>Individuals harboring identical recurring pathogenic variants so far appear to have broadly similar seizure and developmental outcomes, although some cases in which clinical heterogeneity appears to be associated with the same variant are also present in the literature. For example, the <a class="figpopup" href="/books/NBK32534/table/bfns.T.kcnq2_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figbfnsTkcnq2pathogenicvariantsdiscuss" rid-ob="figobbfnsTkcnq2pathogenicvariantsdiscuss">p.Arg213Trp</a>
<i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been reported in a severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual and in a family with BFNS [<a class="bk_pop" href="#bfns.REF.sadewa.2008.167">Sadewa et al 2008</a>, <a class="bk_pop" href="#bfns.REF.milh.2015.2314">Milh et al 2015</a>]. Moreover, although neurodevelopmental outcome was overall poor among individuals with KCNQ2-NEE caused by the recurrent p.Ala294Val variant, and all infants had burst-suppression on EEG, one child appeared less impaired (i.e., sat up and spoke 3 words at age 2 years). Genetic background and environmental factors such as treatment and seizure duration may further influence the phenotypic expression of the variants.</p><p>A few children with KCNQ2-NEE were born from mosaic parents (the pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> detected in blood, skin, and hair root samples ranging from 5% to 30% of cells). The neurologic development of the mosaic parents was normal, although several had neonatal seizures [<a class="bk_pop" href="#bfns.REF.weckhuysen.2012.15">Weckhuysen et al 2012</a>, <a class="bk_pop" href="#bfns.REF.milh.2015.2314">Milh et al 2015</a>]; these &#x0fb01;ndings suggest that in order to cause a persistent neurologic disease, <i>KCNQ2</i> pathogenic variants with a more severe functional effect must be present in a suf&#x0fb01;cient proportion of cells.</p></div><div id="bfns.Penetrance"><h3>Penetrance</h3><p>For KCNQ2-BFNE, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is incomplete, with about 77%-85% of individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KCNQ2</i> showing neonatal or early-infantile seizures [<a class="bk_pop" href="#bfns.REF.plouin.2012">Plouin &#x00026; Neubauer 2012</a>, <a class="bk_pop" href="#bfns.REF.grinton.2015.1071">Grinton et al 2015</a>].</p><p>Penetrance is complete for <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> variants leading to KCNQ2-NEE.</p><p>No age- or sex-related differences have been reported.</p></div><div id="bfns.Nomenclature"><h3>Nomenclature</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> occurrence of neonatal seizures was first reported by <a class="bk_pop" href="#bfns.REF.rett.1964.609">Rett &#x00026; Teubel [1964]</a>, who described an epileptic syndrome in which children in three generations had neonatal seizures that mostly disappeared in girls after six to eight weeks but persisted in boys throughout adolescence. The neonatal seizures were not associated with perinatal complications, such as intracranial bleeding. The term "benign" was added to the designation "familial neonatal convulsions" by <a class="bk_pop" href="#bfns.REF.bjerre.1968.557">Bjerre &#x00026; Corelius [1968]</a>, who described a five-generation family with neonatal convulsions but normal motor and mental development, highlighting the mostly favorable outcome of the syndrome.</p><p>Subsequently it was noted that in rare instances, <i>KCNQ2</i> pathogenic variants can be observed in children who develop a therapy-resistant epileptic encephalopathy shortly after birth and a variable degree of intellectual disability by age four to five years [<a class="bk_pop" href="#bfns.REF.alfonso.1997.249">Alfonso et al 1997</a>, <a class="bk_pop" href="#bfns.REF.dedek.2003.21">Dedek et al 2003</a>, <a class="bk_pop" href="#bfns.REF.borgatti.2004.57">Borgatti et al 2004</a>, <a class="bk_pop" href="#bfns.REF.schmitt.2005.161">Schmitt et al 2005</a>]. Thus, the favorable outcome of this disorder implied by the name "benign" was questioned [<a class="bk_pop" href="#bfns.REF.steinlein.2007.245">Steinlein et al 2007</a>]. More recent reports of certain <i>KCNQ2</i> pathogenic variants leading to a neonatal epileptic encephalopathy with early-onset refractory seizures and intellectual disability of unknown origin have led to proposal of the name "<i>KCNQ2</i> encephalopathy" [<a class="bk_pop" href="#bfns.REF.weckhuysen.2012.15">Weckhuysen et al 2012</a>].</p><p>Because of the variable clinical phenotypes associated to pathogenic variants in <i>KCNQ2</i>, the authors refer to a spectrum of <i>KCNQ2</i>-related diseases ranging from self-limiting KCNQ2-BFNE to severe KCNQ2-NEE.</p></div><div id="bfns.Prevalence"><h3>Prevalence</h3><p><i>KCNQ2</i>-related disorders comprise a large spectrum of phenotypes. Both <i>KCNQ2</i>-related classic BFNE and the recently described KCNQ2-NEE are rare. To date, about 100 families with KCNQ2-BFNE and about 100 individuals with KCNQ2-NEE from many different nationalities have been described in the literature. It is likely that many cases of KCNQ2-BFNE go untested and/or are not reported owing to the brief duration of symptoms and good outcome. KCNQ2-NEE is a very recently described syndrome. Therefore, at present, it is difficult to determine overall prevalence or ethnicity-dependent variability.</p></div></div><div id="bfns.Genetically_Related_Allelic_Disorde"><h2 id="_bfns_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>KCNQ2.</i></p></div><div id="bfns.Differential_Diagnosis"><h2 id="_bfns_Differential_Diagnosis_">Differential Diagnosis</h2><div id="bfns.Other_Causes_of_Benign_Familial_Neo"><h3>Other Causes of Benign Familial Neonatal Epilepsy (BFNE)</h3><p><b><i>KCNQ3,</i></b> a close homolog of <i>KCNQ2</i>, encodes a voltage-gated potassium channel subunit that co-assembles with the <i>KCNQ2</i> protein product [<a class="bk_pop" href="#bfns.REF.wang.1998.1890">Wang et al 1998</a>, <a class="bk_pop" href="#bfns.REF.cooper.2000.4914">Cooper et al 2000</a>]. KCNQ3 is a minor <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> for BFNE [<a class="bk_pop" href="#bfns.REF.charlier.1998.53">Charlier et al 1998</a>]. The clinical characteristics of BFNE caused by pathogenic variants in <i>KCNQ2</i> or in <i>KCNQ3</i> appear indistinguishable; thus, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of both genes is commonly performed when BFNE is suspected. See <a href="/books/n/gene/kcnq3-dis/"><i>KCNQ3</i>-Related Disorders</a>.</p><p><b>Other genetic loci.</b> The existence of other loci associated with BFNE cannot be excluded. <a class="bk_pop" href="#bfns.REF.concolino.2002.214">Concolino et al [2002]</a> reported a family in whom a pericentric inversion of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 5 segregates with BFNE; no linkage to <i>KCNQ2</i> or <i>KCNQ3</i> was found in this family. Among 36 families with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal-onset seizures, three did not have pathogenic variants identified in <i>KCNQ2</i> or <i>KCNQ3</i>, as well as in other genes associated with early-onset epilepsies (<i>SCN2A</i> or <i>PRRT2</i>); in these families, no linkage was found to any other chromosomal region [<a class="bk_pop" href="#bfns.REF.grinton.2015.1071">Grinton et al 2015</a>].</p></div><div id="bfns.Other_Causes_of_Neonatal_Epilepsy"><h3>Other Causes of Neonatal Epilepsy</h3><p>The diagnosis of BFNE is based on the absence of any other explanation for the seizures. The reason for ordering laboratory tests is, therefore, to exclude other possible causes of the seizures.</p><p>Late hypocalcemia, vitamin B<sub>6</sub> deficiency, hyperthyroidism, and benign sleep myoclonus should be excluded. It is also important not to miss a diagnosis of a treatable meningoencephalitis in the early stage or an intracranial hemorrhage. Both of these conditions in neonates lack the typical findings observed in older infants and children, and seizures may be the only early symptom.</p><p>The following laboratory, imaging, and instrumental studies may be helpful for the differential diagnosis:</p><ul><li class="half_rhythm"><div><b>Chemistries</b></div><ul><li class="half_rhythm"><div class="half_rhythm">Basic metabolic panel plus serum concentration of calcium, magnesium, phosphorus</div></li><li class="half_rhythm"><div class="half_rhythm">Evaluation of alpha-AASA levels in serum and urine as a biomarker of <a href="/books/n/gene/pds/">pyridoxine (vitamin B<sub>6</sub>)-dependent seizures</a>, a rare genetic disorder of vitamin B<sub>6</sub> metabolism caused by pathogenic variants in <i>ALDH7A1</i> and characterized by neonatal-onset seizures that are resistant to common anticonvulsants, but controlled by daily treatment with vitamin B<sub>6</sub></div><div class="half_rhythm">In this context it should be noted that in a recent study, a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (c.629G&#x0003e;A; p.Arg210His) was identified in a patient age seven years whose neonatal seizures showed a response to pyridoxine and who had a high plasma-to-CSF pyridoxal 5'-phosphate ratio but no further proof of an inborn error of vitamin B<sub>6</sub> metabolism [<a class="bk_pop" href="#bfns.REF.reid.2016.79">Reid et al 2016</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Thyroid function tests, as neonatal hyperthyroid state and thyrotoxicosis may be associated with excessive tremor and jitteriness, clinical conditions that should be differentiated from seizures</div></li></ul></li><li class="half_rhythm"><div><b>Basic hematologic</b>
<b>labs.</b> CBC, prothrombin time, activated partial thromboplastin time</div></li><li class="half_rhythm"><div><b>Lumbar puncture.</b> Cerebrospinal fluid examination to exclude neonatal meningoencephalitis or occult blood</div></li><li class="half_rhythm"><div><b>MRI and/or CT scan of the brain.</b> Indicated for any individual with neonatal seizures to exclude structural lesions and intracranial hemorrhage</div></li><li class="half_rhythm"><div><b>Electroencephalography.</b> No specific EEG trait characterizes BFNE during neonatal seizures; the interictal EEG is most commonly normal (50%-70% of infants).</div></li></ul><div id="bfns.LaterOnset_Benign_Familial_Seizures"><h4>Later-Onset Benign Familial Seizures</h4><p>Two genetic conditions that can closely resemble BFNE in rare instances are benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile seizures (<b>BFIS</b>), in which seizure onset is around age six months, and benign familial neonatal-infantile seizures (<b>BFNIS</b>), in which seizures display an intermediate age of onset between the neonatal and infantile period [<a class="bk_pop" href="#bfns.REF.berkovic.2004.550">Berkovic et al 2004</a>]. Only a few <i>KCNQ2</i> pathogenic variants have been detected in families with BFIS or BFNIS [<a class="bk_pop" href="#bfns.REF.zhou.2006.691">Zhou et al 2006</a>, <a class="bk_pop" href="#bfns.REF.zara.2013.425">Zara et al 2013</a>].</p><ul><li class="half_rhythm"><div><b>BFIS</b> is genetically distinct from BFNE, with at least three loci being involved.</div><ul><li class="half_rhythm"><div>In the largest percentage of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> families, pathogenic variants in <i>PRRT2</i> can be identified (<a href="/books/n/gene/prrt2-parox/">see <i>PRRT2</i>-Associated Paroxysmal Movement Disorders</a>). <i>PRRT2</i> encodes the proline-rich transmembrane protein 2 (PRRT2), a membrane protein that interacts with the presynaptic protein SNAP-25 [<a class="bk_pop" href="#bfns.REF.heron.2012.152">Heron et al 2012</a>, <a class="bk_pop" href="#bfns.REF.zara.2013.425">Zara et al 2013</a>].</div></li><li class="half_rhythm"><div>Additional families show linkage to <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> 19q12-q13.1 [<a class="bk_pop" href="#bfns.REF.guipponi.1997.473">Guipponi et al 1997</a>] (unknown <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>; OMIM <a href="http://omim.org/entry/601764" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601764</a>) and 2q24, the latter involving <i>SCN2A</i>, encoding one of the main pore-forming subunits of neuronal voltage-gated sodium channels [<a class="bk_pop" href="#bfns.REF.striano.2006.218">Striano et al 2006</a>] (OMIM <a href="http://omim.org/entry/607745" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">607745</a>).</div></li></ul></li><li class="half_rhythm"><div><b>BFNIS</b> is mainly caused by pathogenic variants in <i>SCN2A</i> [<a class="bk_pop" href="#bfns.REF.heron.2002.851">Heron et al 2002</a>, <a class="bk_pop" href="#bfns.REF.berkovic.2004.550">Berkovic et al 2004</a>] , and less frequently in <i>KCNQ2</i> [<a class="bk_pop" href="#bfns.REF.zara.2013.425">Zara et al 2013</a>].</div></li></ul></div><div id="bfns.EarlyInfantile_Epileptic_Encephalop"><h4>Early-Infantile Epileptic Encephalopathies (EIEEs)</h4><p><i>KCNQ2</i>-related neonatal epileptic encephalopathy (NEE) (recently classified as early-infantile epileptic encephalopathy type 7, or EIEE 7) should be distinguished from other early-onset epileptic encephalopathies, also characterized by recurrent seizures, prominent interictal epileptiform discharges, and poor neurocognitive development. Although epileptic encephalopathies are often associated with structural brain defects or inherited metabolic disorders, pathogenic variants may also be involved in the development of epileptic encephalopathies even when no clear genetic inheritance patterns or <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> exist [<a class="bk_pop" href="#bfns.REF.g_rsoy.2016.523">G&#x000fc;rsoy &#x00026; Er&#x000e7;al 2016</a>]. The EIEEs are genetically very heterogeneous. Based on the genes in which pathogenic variants have been found, current classification of EIEE is as follows:</p><div id="bfns.T.genetic_heterogeneity_of_earlyinf" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Genetic Heterogeneity of Early-Infantile Epileptic Encephalopathies (EIEEs)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32534/table/bfns.T.genetic_heterogeneity_of_earlyinf/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bfns.T.genetic_heterogeneity_of_earlyinf_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disease Name (OMIM/<i>GeneReview</i>)</th><th id="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th></tr></thead><tbody><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE1 (<a href="http://omim.org/entry/308350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">308350</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARX</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE2 (<a href="http://www.omim.org/entry/300672" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300672</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CDKL5</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE3 (<a href="http://www.omim.org/entry/609304" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609304</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC25A22</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE4 (<a href="/books/n/gene/stxbp1-ee/"><i>STXBP1</i> Encephalopathy with Epilepsy</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>STXBP1</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE5 (<a href="http://www.omim.org/entry/613477" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613477</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPTAN1</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE6 (<a href="/books/n/gene/gefs/"><i>SCN1A</i>-Related Seizure Disorders</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN1A</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE7 (<a href="http://www.omim.org/entry/613720" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613720</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNQ2</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE8 (<a href="http://www.omim.org/entry/300607" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300607</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARHGEF9</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE9 (<a href="http://www.omim.org/entry/300088" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300088</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PCDH19</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE10 (<a href="http://www.omim.org/entry/613402" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613402</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PNKP</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE11 (<a href="http://www.omim.org/entry/613721" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613721</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN2A</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE12 (<a href="http://www.omim.org/entry/613722" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613722</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLCB1</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE13 (<a href="/books/n/gene/scn8a-ee/"><i>SCN8A</i>-Related Epilepsy with Encephalopathy</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN8A</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE14 (<a href="/books/n/gene/kcnt1-epilepsy/"><i>KCNT1</i>-Related Epilepsy</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNT1</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE15 (<a href="http://www.omim.org/entry/615006" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615006</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ST3GAL3</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE16 (<a href="/books/n/gene/tbc1d24-dis/"><i>TBC1D24</i>-Related Disorders</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TBC1D24</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE17 (<a href="http://www.omim.org/entry/615473" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615473</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNAO1</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE18 (<a href="http://www.omim.org/entry/615476" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615476</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SZT2</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE19 (<a href="http://www.omim.org/entry/615744" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615744</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GABRA1</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE20 (<a href="http://www.omim.org/entry/300868" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300868</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PIGA</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE21 (<a href="http://www.omim.org/entry/615833" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615833</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NECAP1</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE22 (<a href="http://www.omim.org/entry/300896" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300896</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC35A2</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE23 (<a href="http://www.omim.org/entry/615859" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615859</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DOCK7</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE24 (<a href="http://www.omim.org/entry/615871" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615871</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HCN1</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE25 (<a href="http://www.omim.org/entry/615905" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615905</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC13A5</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE26 (<a href="http://www.omim.org/entry/616056" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615056</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNB1</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE27 (<a href="/books/n/gene/grin2b/"><i>GRIN2B</i>-Related Neurodevelopmental Disorder</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GRIN2B</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE28 (<a href="http://www.omim.org/entry/616211" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616211</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WWOX</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE29 (<a href="http://www.omim.org/entry/616339" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616339</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AARS1</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE30 (<a href="http://www.omim.org/entry/616341" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616341</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SIK1</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE31 (<a href="http://www.omim.org/entry/616346" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616346</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DNM1</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE32 (<a href="http://www.omim.org/entry/616366" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616366</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNA2</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE33 (<a href="http://www.omim.org/entry/616409" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616409</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EEF1A2</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE34 (<a href="/books/n/gene/slc12a5-e/"><i>SLC12A5</i>-Related Epilepsy of Infancy with Migrating Focal Seizures</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC12A5</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE35 (<a href="http://www.omim.org/entry/616647" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616647</a>)</td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ITPA</i></td><td headers="hd_h_bfns.T.genetic_heterogeneity_of_earlyinf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = autodomal dominant; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; EIEE = early-infantile epileptic encephalopathy; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd></dl></div></div></div><p>Several of these EIEEs can have neonatal onset of seizures, including those associated with pathogenic variants in <i>ARX</i>, <i>SLC25A22</i>, <i>CDKL5</i>, <i>STXBP1</i>, <i>PLCB1</i>, <i>SCN2A</i>, <i>KCNT1</i>, and <i>SLC13A5</i>. Some specific clinical features can point toward a certain <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> other than <i>KCNQ2</i>, such as the presence of prominent movement disorders in <i>ARX-</i> and <i>SCN2A</i>-related EIEE [<a class="bk_pop" href="#bfns.REF.howell.2015.958">Howell et al 2015</a>], a hypermotor-tonic-spasm seizure <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in girls with pathogenic <i>CDKL5</i> variants [<a class="bk_pop" href="#bfns.REF.klein.2011.1436">Klein et al 2011</a>], or convulsive seizures and hypodontia in <i>SLC13A5</i>-related EIEE [<a class="bk_pop" href="#bfns.REF.hardies.2015.3238">Hardies et al 2015</a>]. Also, unlike many EIEEs, those caused by <i>KCNQ2</i> pathogenic variants are characterized by decreasing frequency of seizures over the first few months or years of life.</p><p><b>Ohtahara syndrome</b> is the most severe and the earliest developing age-related epileptic encephalopathy, characterized by tonic seizures occurring within the first three months of life, often within the first two weeks. Seizures that can be either generalized or lateralized may occur singly or in clusters, and are independent of the sleep cycle. The EEG in individuals with Ohtahara syndrome typically shows bursts of high-amplitude spikes and polyspikes that alternate at a regular rate with periods of electric suppression (suppression-burst EEG pattern). Psychomotor development and prognosis are generally very poor. Clinical features of Ohtahara syndrome can be caused by pathogenic variants in several genes, including <i>ARX</i> (EIEE1), <i>CDKL5</i> (EIEE2), <i>SLC25A22</i> (EIEE3), <i>STXBP1</i> (<a href="/books/n/gene/stxbp1-ee/">EIEE4</a>), and <i>SCN2A</i> (EIEE11) [<a class="bk_pop" href="#bfns.REF.mastrangelo.2012.24">Mastrangelo &#x00026; Leuzzi 2012</a>, <a class="bk_pop" href="#bfns.REF.pavone.2012.459">Pavone et al 2012</a>, <a class="bk_pop" href="#bfns.REF.mastrangelo.2015.119">Mastrangelo 2015</a>]. Since its description, several individuals diagnosed with Ohtahara syndrome have been found to carry pathogenic variants in <i>KCNQ2</i> (EIEE7).</p><p><b>Mosaic <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 20 ring [r(20)]</b> is a chromosomal disorder that has been associated with a rare syndrome, consisting of refractory epilepsy with non-convulsive status epilepticus (NCSE) and cognitive problems [<a class="bk_pop" href="#bfns.REF.inoue.1997.939">Inoue et al 1997</a>].</p><p><a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analyses have not shown deletions of the telomeric and subtelomeric <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 20 regions and, more particularly, no <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>CHRNA4</i> or <i>KCNQ2</i> [<a class="bk_pop" href="#bfns.REF.zou.2006.1696">Zou et al 2006</a>, <a class="bk_pop" href="#bfns.REF.elghezal.2007.441">Elghezal et al 2007</a>]. Although differential diagnosis is rather straightforward because of the later (non-neonatal) onset of seizures in r(20), the direct physical link between distal 20p and 20q segments in the ring structure may disturb the correct expression or the regulation of genes located near the telomeric regions, including subtelomeric <i>CHRNA4</i> and <i>KCNQ2</i> [<a class="bk_pop" href="#bfns.REF.giardino.2010.146">Giardino et al 2010</a>].</p></div></div></div><div id="bfns.Management"><h2 id="_bfns_Management_">Management</h2><div id="bfns.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p><i>KCNQ2</i>-related disorders represent a broad prognostic spectrum, and evaluation following a positive <i>KCNQ2</i> genetic test differs depending on severity of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p><b>Individuals with benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE)</b></p><ul><li class="half_rhythm"><div>In-depth neurologic examination</div></li><li class="half_rhythm"><div>Developmental evaluation</div></li></ul><p><b>Individuals with neonatal epileptic encephalopathy (NEE)</b></p><ul><li class="half_rhythm"><div>Video EEG monitoring including sleep phase to obtain information on presence of seizures. A burst suppression EEG pattern might only be seen during sleep.</div></li><li class="half_rhythm"><div>Cognitive and behavioral neuropsychological testing</div></li><li class="half_rhythm"><div>Assessment of digestive and other non-neurologic comorbidities</div></li></ul><p><b>All individuals with a <i>KCNQ2</i>-related disorder.</b> Consultation with a clinical geneticist and/or genetic counselor is also recommended.</p></div><div id="bfns.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>KCNQ2-BFNE.</b> Seizures in individuals with BFNE are generally controlled with conventional antiepileptic treatment. Phenobarbital and phenytoin (loading doses of 15-20 mg/kg&#x0037e; maintenance doses of 3-4 mg/kg for both agents) [<a class="bk_pop" href="#bfns.REF.painter.1981.1107">Painter et al 1981</a>] are the antiepileptic drugs (AEDs) most commonly used to treat neonatal seizures.</p><p>Because of concerns over the suboptimal effectiveness and safety of phenytoin and phenobarbital, other anticonvulsants, such as levetiracetam and topiramate, are often used (off-label and despite limited data) in neonates with refractory seizures [<a class="bk_pop" href="#bfns.REF.tulloch.2012.31">Tulloch et al 2012</a>]. Refractory seizures are uncommon in <i>KCNQ2</i>-related BFNE.</p><p><b>KCNQ2-NEE.</b> Children with <i>KCNQ2</i>-related neonatal epileptic encephalopathy generally present with tonic seizures accompanied by motor and autonomic features, similar to seizures in KCNQ2-BFNE. However, individuals with KCNQ2-NEE clearly differ from those with KCNQ2-BFNE as to seizure response. Although seizure response to any of the AEDs has been described in isolated patients, many patients at onset show multiple daily seizures resistant to multiple common old- and new-generation AEDs, alone or in combination. Seizures then tend to gradually decrease by age nine months to four years [<a class="bk_pop" href="#bfns.REF.weckhuysen.2012.15">Weckhuysen et al 2012</a>].</p><p>A favorable response to drugs acting on voltage-gated sodium channels has been suggested in several studies [<a class="bk_pop" href="#bfns.REF.kato.2013.1282">Kato et al 2013</a>, <a class="bk_pop" href="#bfns.REF.weckhuysen.2013.1697">Weckhuysen et al 2013</a>, <a class="bk_pop" href="#bfns.REF.numis.2014.368">Numis et al 2014</a>, <a class="bk_pop" href="#bfns.REF.pisano.2015.685">Pisano et al 2015</a>]. It has been suggested that early effective treatment reduces cognitive disability [<a class="bk_pop" href="#bfns.REF.pisano.2015.685">Pisano et al 2015</a>]; however, it remains a matter of debate whether early control of seizures translates to better neuropsychological outcome.</p><p>VGB or ACTH therapy can be tried for treatment of infantile spasms that can occur during the course of the disease [<a class="bk_pop" href="#bfns.REF.dedek.2003.21">Dedek et al 2003</a>, <a class="bk_pop" href="#bfns.REF.borgatti.2004.57">Borgatti et al 2004</a>, <a class="bk_pop" href="#bfns.REF.serino.2013.158">Serino et al 2013</a>].</p><p>Management should further focus on the optimization of the patient's functional and communication skills. A multidisciplinary team approach including physiotherapists, speech therapists, and behavioral therapists is best suited to addressing the individual's needs. Augmentative communication techniques can be valuable for many patients.</p></div><div id="bfns.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>As seizure frequency tends to decrease with age, the option to taper and eventually stop AED after a sufficient seizure-free period should be considered in order to prevent complications of long-term AED use. Some children may require lifelong antiepileptic treatment.</p></div><div id="bfns.Surveillance"><h3>Surveillance</h3><p><b>KCNQ2-BFNE.</b> EEG at age three, 12, and 24 months is appropriate. The EEG at 24 months should be normal.</p><p><b>KCNQ<i>2</i>-NEE.</b> Video-EEG monitoring is appropriate when new or different seizure types are suspected.</p><p>Serial neuropsychological evaluation of neurologic, cognitive, and behavioral problems is advised.</p><p>Regular follow up by a multidisciplinary team with particular attention to nutritional intake, gastrointestinal function, mobility, and communication skills is recommended.</p></div><div id="bfns.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>In patients with known <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> pathogenic variants in <i>KCNQ2</i>, the use of the potassium channel opener retigabine/ezogabine may be contraindicated.</p></div><div id="bfns.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#bfns.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="bfns.Pregnancy_Management"><h3>Pregnancy Management</h3><p>The pregnancy management of a woman with a <i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and epilepsy does not differ from that of any other pregnant woman with a seizure disorder.</p><p>A fetus with a <i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may have neonatal seizures in the first few days of life. Therefore, a woman who is carrying a fetus at risk of inheriting a <i>KCNQ2</i>-related disorder should consider delivering in a hospital with a neonatal intensive care unit.</p></div><div id="bfns.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>A recent report described a positive effect of vitamin B<sub>6</sub> on seizures in a few patients with KCNQ2-NEE [<a class="bk_pop" href="#bfns.REF.reid.2016.79">Reid et al 2016</a>], but further studies are needed to confirm the antiepileptic effect of pyridoxine in the absence of an inherited disorder of vitamin B<sub>6</sub> metabolism.</p><p>The selective neuronal KCNQ potassium channel opener retigabine/ezogabine, an AED introduced in 2013 as adjunctive treatment of partial epilepsy in adults [<a class="bk_pop" href="#bfns.REF.porter.2012.103">Porter et al 2012</a>], may represent a targeted therapy for KCNQ2-NEE. However, the discovery of additional side effects in the early post-marketing (blue discoloration of skin and retina) raise concerns about its use in children. Although a good effect on seizures was described in one patient [<a class="bk_pop" href="#bfns.REF.weckhuysen.2013.1697">Weckhuysen et al 2013</a>], additional experience has not yet been reported. Furthermore, given existing in vitro evidence that some variants may lead to a gain of function, the use of retigabine/ezogabine may theoretically even be contraindicated in some patients. Further studies are needed to address whether early use of the drug in specific patient groups is effective.</p><p>Search <a href="http://clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Clinical Trials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="bfns.Genetic_Counseling"><h2 id="_bfns_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="bfns.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>KCNQ2</i>-related disorders are expressed in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="bfns.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with <i>KCNQ2</i>-related benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (KCNQ2-BFNE) inherited a <i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a parent.</div></li><li class="half_rhythm"><div>Alternatively, a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with KCNQ2-BFNE may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. <i>De novo</i> pathogenic variants have been reported in eight unrelated patients with KCNQ2-BFNE [<a class="bk_pop" href="#bfns.REF.claes.2004.2155">Claes et al 2004</a>, <a class="bk_pop" href="#bfns.REF.steinlein.2007.245">Steinlein et al 2007</a>, <a class="bk_pop" href="#bfns.REF.sadewa.2008.167">Sadewa et al 2008</a>, <a class="bk_pop" href="#bfns.REF.neubauer.2008.177">Neubauer et al 2008</a>, <a class="bk_pop" href="#bfns.REF.ishii.2009.27">Ishii et al 2009</a>, <a class="bk_pop" href="#bfns.REF.miceli.2009.501">Miceli et al 2009</a>, <a class="bk_pop" href="#bfns.REF.soldovieri.2014.356">Soldovieri et al 2014</a>].</div></li><li class="half_rhythm"><div>Most individuals diagnosed with <i>KCNQ2</i>-related neonatal epileptic encephalopathy (KCNQ2-NEE) have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#bfns.REF.saitsu.2012.298">Saitsu et al 2012</a>, <a class="bk_pop" href="#bfns.REF.weckhuysen.2012.15">Weckhuysen et al 2012</a>, <a class="bk_pop" href="#bfns.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#bfns.REF.carvill.2013.825">Carvill et al 2013</a>, <a class="bk_pop" href="#bfns.REF.kato.2013.1282">Kato et al 2013</a>, <a class="bk_pop" href="#bfns.REF.milh.2013.80">Milh et al 2013</a>, <a class="bk_pop" href="#bfns.REF.weckhuysen.2013.1697">Weckhuysen et al 2013</a>, <a class="bk_pop" href="#bfns.REF.allen.2014.e99">Allen et al 2014</a>, <a class="bk_pop" href="#bfns.REF.dalen_meursvan_der_schoor.2014.136">Dalen Meurs-van der Schoor et al 2014</a>, <a class="bk_pop" href="#bfns.REF.martin.2014.3200">Martin et al 2014</a>, <a class="bk_pop" href="#bfns.REF.milh.2015.2314">Milh et al 2015</a>, <a class="bk_pop" href="#bfns.REF.pisano.2015.685">Pisano et al 2015</a>].</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <i>KCNQ2</i>-related disorder.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> in a parent.</div><ul><li class="half_rhythm"><div><b>KCNQ2-BFNE.</b> A <i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in two sibs with KCNQ2-BFNE was not identified in the leukocyte DNA of either parent suggesting parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in this family [<a class="bk_pop" href="#bfns.REF.sadewa.2008.167">Sadewa et al 2008</a>].</div></li><li class="half_rhythm"><div><b>KCNQ2-NEE.</b> Several cases of <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> (ranging from 5% to 30%) have been reported in parents of patients with KCNQ2-NEE [<a class="bk_pop" href="#bfns.REF.weckhuysen.2012.15">Weckhuysen et al 2012</a>, <a class="bk_pop" href="#bfns.REF.kato.2013.1282">Kato et al 2013</a>, <a class="bk_pop" href="#bfns.REF.milh.2015.2314">Milh et al 2015</a>]. The neurologic development of the mosaic parents was normal, although several had neonatal seizures [<a class="bk_pop" href="#bfns.REF.weckhuysen.2012.15">Weckhuysen et al 2012</a>, <a class="bk_pop" href="#bfns.REF.milh.2015.2314">Milh et al 2015</a>].</div></li></ul></li><li class="half_rhythm"><div>Note: The family history of some individuals diagnosed with a <i>KCNQ2</i>-related disorder may appear to be negative because of failure to recognize the disorder in family members or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents: if a parent of the proband has a <i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the pathogenic variant and being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> is 50%.</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk for a <i>KCNQ2</i>-related disorder because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> or somatic/<a class="def" href="/books/n/gene/glossary/def-item/gonadal-mosaicism/">gonadal mosaicism</a> in a parent.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with KCNQ2-BFNE has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div><ul><li class="half_rhythm"><div class="half_rhythm">Note: The possibility of <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> should be evaluated in probands with KCNQ2-BFNE who have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant not previously described in association with a benign <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. This is important because individuals with somatic mosaicism for a <i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may present themselves with BFNE, but are at risk for offspring with KCNQ2-NEE [<a class="bk_pop" href="#bfns.REF.weckhuysen.2012.15">Weckhuysen et al 2012</a>, <a class="bk_pop" href="#bfns.REF.milh.2015.2314">Milh et al 2015</a>].</div><div class="half_rhythm">The level of <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> in blood or other tissues may not reflect the level of mosacism in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>.</div></li></ul></li><li class="half_rhythm"><div>Given the severity of the disease course, individuals with KCNQ2-NEE rarely reproduce.</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has the <i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="bfns.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></b>. When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to parents of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and young adults who are affected.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="bfns.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once a <i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="bfns.Resources"><h2 id="_bfns_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>KCNQ2 Cure Alliance</b></div><div>3700 Quebec Street</div><div>Unit 100-118</div><div>Denver CO 80207</div><div><b>Phone:</b> 303-887-9532</div><div><b>Email:</b> info@KCNQ2Cure.org</div><div><a href="http://www.kcnq2cure.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.kcnq2cure.org</a></div></li><li class="half_rhythm"><div><b>The Jack Pribaz Foundation</b></div><div>PO Box 813</div><div>Wheaton IL 60187</div><div><b>Phone:</b> 708-308-1440</div><div><b>Email:</b> info@kcnq2.org</div><div><a href="http://kcnq2.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.kcnq2.org</a></div></li><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>Canadian Epilepsy Alliance</b></div><div>Canada</div><div><b>Phone:</b> 1-866-EPILEPSY (1-866-374-5377)</div><div><a href="http://epilepsymatters.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsymatters.com</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li><li class="half_rhythm"><div><b>The RIKEE Project (Rational Intervention for KCNQ2/3 Epileptic Encephalopathy) Patient Registry</b></div><div><b>Phone:</b> 713-798-3464</div><div><b>Fax:</b> 713-798-3455</div><div><a href="http://www.rikee.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rikee.org</a></div></li></ul></div><div id="bfns.Molecular_Genetics"><h2 id="_bfns_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="bfns.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>KCNQ2-Related Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32534/table/bfns.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bfns.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_bfns.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_bfns.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_bfns.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_bfns.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_bfns.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_bfns.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_bfns.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_bfns.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">EBN1</td><td headers="hd_b_bfns.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3785" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNQ2</i></a></td><td headers="hd_b_bfns.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3785" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">20q13<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_bfns.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O43526" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Potassium voltage-gated channel subfamily KQT member 2</a></td><td headers="hd_b_bfns.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/KCNQ2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ2 database</a><br /><a href="http://www.rikee.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RIKEE KCNQ2-5-related illness database</a></td><td headers="hd_b_bfns.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNQ2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ2</a></td><td headers="hd_b_bfns.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNQ2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="bfns.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="bfns.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for KCNQ2-Related Disorders (<a href="/omim/121200,602235,613720" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32534/table/bfns.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bfns.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/121200" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">121200</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602235" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602235</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 2; KCNQ2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613720" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613720</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7</td></tr></tbody></table></div></div><div id="bfns.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The <i>KCNQ</i> potassium channel <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> subfamily consists of five members (<i>KCNQ1-5</i>), each encoding a subunit of a voltage-gated potassium channel. Each subunit shows distinct tissue distribution and subcellular localization, as well as biophysical, pharmacologic, and pathophysiologic properties [<a class="bk_pop" href="#bfns.REF.miceli.2008.65">Miceli et al 2008</a>, <a class="bk_pop" href="#bfns.REF.soldovieri.2011.365">Soldovieri et al 2011</a>].</p><p>KCNQ subunits, similarly to other voltage-gated potassium channel subunits, include six transmembrane domains, with cytoplasmic N-terminal (short) and C-terminal (longer) regions. In neurons, KCNQ2, KCNQ3, KCNQ4, and KCNQ5 subunits (either as homomultimers or heteromultimers) represent the molecular basis of the M-current (I<sub>KM</sub>), a K<sup>+</sup>-selective, non-<a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a>, and slowly activating/deactivating current [<a class="bk_pop" href="#bfns.REF.brown.1980.673">Brown &#x00026; Adams 1980</a>, <a class="bk_pop" href="#bfns.REF.wang.1998.1890">Wang et al 1998</a>], showing a critical role in spike-frequency adaptation and neuronal excitability control.</p><p>In addition to <i>KCNQ2</i>, other <i>KCNQ</i> genes have a role in human genetic disease. In humans, pathogenic variants in <i>KCNQ1</i> are responsible for one form of long QT syndrome (LQTS-1) [<a class="bk_pop" href="#bfns.REF.wang.1996.17">Wang et al 1996</a>], as well as for <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> atrial fibrillation [<a class="bk_pop" href="#bfns.REF.chen.2003.251">Chen et al 2003</a>] and the short QT syndrome [<a class="bk_pop" href="#bfns.REF.bellocq.2004.2394">Bellocq et al 2004</a>]. Pathogenic variants in <i>KCNQ4</i>, expressed mainly in the cochlea and central auditory pathways, cause a rare form of nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hearing loss (<a href="/books/n/gene/dfna2/">DFNA2</a>) [<a class="bk_pop" href="#bfns.REF.kubisch.1999.437">Kubisch et al 1999</a>]. Finally, variants in <i>KCNQ3</i> are rare causes of BFNE [<a class="bk_pop" href="#bfns.REF.charlier.1998.53">Charlier et al 1998</a>].</p><p><b>Gene structure.</b> At least five transcript variants have been described for <i>KCNQ2</i>.</p><p>The transcript variant 1 (<a href="/nuccore/NM_172107.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_172107.2</a>) encodes the longest isoform, isoform a, consisting of 3,251 bp and 17 exons.</p><p>Transcript variants 2, 3, and 4 (<a href="/nuccore/NM_172106.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_172106.1</a>, <a href="/nuccore/NM_004518.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004518.4</a>, and <a href="/nuccore/NM_172108.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_172108.3</a>, respectively), encode <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> (b, c, and d, respectively) that are shorter than isoform a:</p><ul><li class="half_rhythm"><div>Transcript variant 2 lacks an <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> compared to variant 1 and the encoded isoform b lacks the amino-acidic stretch from Lys417 to Ser434.</div></li><li class="half_rhythm"><div>Transcript variant 3 lacks one more <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> compared to variant 2, resulting in a shorter isoform (c) without amino acids Lys417-Ser434 and Ser373-Ser382. This variant shows a different 3'-UTR.</div></li><li class="half_rhythm"><div>Isoform d is encoded by transcript variant 4, which lacks two <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> exons, resulting in a protein product without Lys417-Ser446 and the single residue Glu509.</div></li></ul><p>Transcript variant 5 (<a href="/nuccore/NM_172109.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_172109.1</a>), the shortest one, encodes a truncated isoform (isoform e) that shows a distinct C-terminus. In fact, it uses a different <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> site in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>, resulting in a frameshift after the Tyr375 residue. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK32534/#bfns.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The first pathogenic variants in <i>KCNQ2-</i>related disorders were described in 1998 [<a class="bk_pop" href="#bfns.REF.biervert.1998.403">Biervert et al 1998</a>, <a class="bk_pop" href="#bfns.REF.singh.1998.25">Singh et al 1998</a>]. <a class="figpopup" href="/books/NBK32534/table/bfns.T.kcnq2_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figbfnsTkcnq2pathogenicvariantsdiscuss" rid-ob="figobbfnsTkcnq2pathogenicvariantsdiscuss">Table 3</a> lists pathogenic variants discussed in this <i>GeneReview</i>.</p><p>The spectrum of pathogenic variants causing <i>KCNQ2</i>-related disorders varies by disorder:</p><ul><li class="half_rhythm"><div><b>KCNQ2-BFNE.</b> Pathogenic variants include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, splice, stop, and frameshift variants as well as <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions; variants occur throughout the gene, leading to sequence changes distributed throughout the protein.</div></li><li class="half_rhythm"><div><b>KCNQ2-NEE.</b> Pathogenic variants are all <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and cluster in four functionally important protein domains: the voltage sensor, the pore, the C-terminus proximal region (important for modulation by second messengers), and the calmodulin-binding B helix region.</div></li></ul><div id="bfns.T.kcnq2_pathogenic_variants_discuss" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>KCNQ2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32534/table/bfns.T.kcnq2_pathogenic_variants_discuss/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bfns.T.kcnq2_pathogenic_variants_discuss_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.629G&#x0003e;A</td><td headers="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg210His</td><td headers="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_172107.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_172107<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.637C&#x0003e;T</td><td headers="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg213Trp</td></tr><tr><td headers="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.638G&#x0003e;A</td><td headers="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg213Gln</td></tr><tr><td headers="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.881C&#x0003e;T</td><td headers="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala294Val</td></tr><tr><td headers="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.881C&#x0003e;G</td><td headers="hd_h_bfns.T.kcnq2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala294Gly</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>KCNQ2</i> (also known as <i>Kv7.2</i>) encodes for voltage-gated potassium channel subunits that are mainly (though not exclusively) expressed in the nervous system. KCNQ2 subunits form heteromultimeric channels with homologous subunits encoded by other KCNQ members expressed in the brain. Heterotetrameric channels formed by KCNQ2 and KCNQ3 subunits are believed to play a major role in mediating the so-called "M-current (I<sub>KM</sub>)," a slowly activating, non-<a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a> potassium conductance that inhibits neuronal excitability. Suppression of I<sub>KM</sub> on activation of G-protein-coupled receptors (including muscarinic receptors, hence the term "M-current") increases neuronal excitability.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Missense variants identified in BFNE lead to a 25%-50% reduction of the potassium current [<a class="bk_pop" href="#bfns.REF.schroeder.1998.687">Schroeder et al 1998</a>, <a class="bk_pop" href="#bfns.REF.singh.2003.2726">Singh et al 2003</a>, <a class="bk_pop" href="#bfns.REF.soldovieri.2006.418">Soldovieri et al 2006</a>]. Functional studies suggest that in most cases a decrease of I<sub>KM</sub> of only 25% is sufficient to cause BFNE, arguing in favor of <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> as the primary pathogenic mechanism for BFNE.</p><p>Various molecular mechanisms appear responsible for the mutation-induced current decrease, including a reduced number of functional channels in the plasma membrane, changes in the subcellular targeting of the channels [<a class="bk_pop" href="#bfns.REF.abidi.2015.80">Abidi et al 2015</a>], an altered regulation of their function by associated proteins (e.g., calmodulin, Ankirin-G, syntaxin-1A), and a reduced sensitivity to changes in membrane potential by correctly assembled channels [<a class="bk_pop" href="#bfns.REF.dedek.2001.12272">Dedek et al 2001</a>, <a class="bk_pop" href="#bfns.REF.castaldo.2002.rc199">Castaldo et al 2002</a>, <a class="bk_pop" href="#bfns.REF.miceli.2013.4386">Miceli et al 2013</a>, <a class="bk_pop" href="#bfns.REF.ambrosino.2015.1856">Ambrosino et al 2015</a>].</p><p>More severe consequences (often with <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effects) on channel function and/or subcellular localization have been recently associated with pathogenic variants causing KCNQ2-NEE, suggesting that clinical disease severity may be related to the extent of functional K<sup>+</sup> channel impairment [<a class="bk_pop" href="#bfns.REF.miceli.2013.4386">Miceli et al 2013</a>, <a class="bk_pop" href="#bfns.REF.orhan.2014.382">Orhan et al 2014</a>, <a class="bk_pop" href="#bfns.REF.abidi.2015.80">Abidi et al 2015</a>]. In fact, in comparative studies evaluating two different variants affecting the same residue in the KCNQ2 S4 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (p.Arg213Trp, found in KCNQ2-BFNE and p.Arg213Gln, found in KCNQ2-NEE) [<a class="bk_pop" href="#bfns.REF.sadewa.2008.167">Sadewa et al 2008</a>, <a class="bk_pop" href="#bfns.REF.weckhuysen.2012.15">Weckhuysen et al 2012</a>], the NEE-associated p.Arg213Gln <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was found to cause more abnormal functional changes than the BFNE-associated p.Arg213Trp pathogenic variant. In addition, while a recurrent <i>KCNQ2</i> variant causing KCNQ2-NEE (p.Ala294Val) diminished the axonal targeting of KCNQ channels, another variant affecting the same residue but found in a family with KCNQ2-BFNE (p.Ala294Gly) failed to affect channel localization to the axon initial segment [<a class="bk_pop" href="#bfns.REF.abidi.2015.80">Abidi et al 2015</a>].</p><p>More recently, three KCNQ2-NEE-causing pathogenic variants have been shown to cause a stabilization of the activated stated of the channel, thereby producing a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> effect, which is opposite to the <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> effects produced by previously studied pathogenic variants [<a class="bk_pop" href="#bfns.REF.miceli.2015.3782">Miceli et al 2015</a>]. Whether distinct clinical features can be associated with these gain-of-function variants is currently under investigation.</p></div></div><div id="bfns.References"><h2 id="_bfns_References_">References</h2><div id="bfns.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.abidi.2015.80">Abidi A, Devaux JJ, Molinari F, Alcaraz G, Michon FX, Sutera-Sardo J, Becq H, Lacoste C, Altuzarra C, Afenjar A, Mignot C, Doummar D, Isidor B, Guyen SN, Colin E, De La Vaissi&#x000e8;re S, Haye D, Trauffler A, Badens C, Prieur F, Lesca G, Villard L, Milh M, Aniksztejn L. A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels. <span><span class="ref-journal">Neurobiol Dis. </span>2015;<span class="ref-vol">80</span>:80–92.</span> [<a href="/pubmed/26007637" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26007637</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.allen.2013.217">Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR. De novo mutations in epileptic encephalopathies. <span><span class="ref-journal">Nature. </span>2013;<span class="ref-vol">501</span>:217–21.</span> [<a href="/pmc/articles/PMC3773011/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3773011</span></a>] [<a href="/pubmed/23934111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23934111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.allen.2014.e99">Allen NM, Mannion M, Conroy J, Lynch SA, Shahwan A, Lynch B, King MD. The variable phenotypes of KCNQ-related epilepsy. <span><span class="ref-journal">Epilepsia. </span>2014;<span class="ref-vol">55</span>:e99–105.</span> [<a href="/pubmed/25052858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25052858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.alfonso.1997.249">Alfonso I, Hahn JS, Papazian O, Martinez YL, Reyes MA, Aicardi J. Bilateral tonic-clonic epileptic seizures in non-benign familial neonatal convulsions. <span><span class="ref-journal">Pediatr Neurol. </span>1997;<span class="ref-vol">16</span>:249–51.</span> [<a href="/pubmed/9165519" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9165519</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.ambrosino.2015.1856">Ambrosino P, Alaimo A, Bartollino S, Manocchio L, De Maria M, Mosca I, Gomis-Perez C, Alberdi A, Scambia G, Lesca G, Villarroel A, Taglialatela M, Soldovieri MV. Epilepsy-causing mutations in Kv7.2 C-terminus affect binding and functional modulation by calmodulin. <span><span class="ref-journal">Biochim Biophys Acta. </span>2015;<span class="ref-vol">1852</span>:1856–66.</span> [<a href="/pubmed/26073431" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26073431</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.bellocq.2004.2394">Bellocq C, van Ginneken AC, Bezzina CR, Alders M, Escande D, Mannens MM, Bar&#x000f3; I, Wilde AA. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. <span><span class="ref-journal">Circulation. </span>2004;<span class="ref-vol">109</span>:2394–7.</span> [<a href="/pubmed/15159330" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15159330</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.berg.2010.676">Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Mosh&#x000e9; SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009. <span><span class="ref-journal">Epilepsia. </span>2010;<span class="ref-vol">51</span>:676–85.</span> [<a href="/pubmed/20196795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20196795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.berkovic.2004.550">Berkovic SF, Heron SE, Giordano L, Marini C, Guerrini R, Kaplan RE, Gambardella A, Steinlein OK, Grinton BE, Dean JT, Bordo L, Hodgson BL, Yamamoto T, Mulley JC, Zara F, Scheffer IE. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. <span><span class="ref-journal">Ann Neurol. </span>2004;<span class="ref-vol">55</span>:550–7.</span> [<a href="/pubmed/15048894" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15048894</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.biervert.1998.403">Biervert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, Jentsch TJ, Steinlein OK. A potassium channel mutation in neonatal human epilepsy. <span><span class="ref-journal">Science. </span>1998;<span class="ref-vol">279</span>:403–6.</span> [<a href="/pubmed/9430594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9430594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.bjerre.1968.557">Bjerre I, Corelius E. Benign familial neonatal convulsions. <span><span class="ref-journal">Acta Paediatr Scand. </span>1968;<span class="ref-vol">57</span>:557–61.</span> [<a href="/pubmed/5706374" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5706374</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.blumkin.2012.356">Blumkin L, Suls A, Deconinck T, De Jonghe P, Linder I, Kivity S, Dabby R, Leshinsky-Silver E, Lev D, Lerman-Sagie T. Neonatal seizures associated with a severe neonatal myoclonus like dyskinesia due to a familial KCNQ2 gene mutation. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2012;<span class="ref-vol">16</span>:356–60.</span> [<a href="/pubmed/22169383" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22169383</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.borgatti.2004.57">Borgatti R, Zucca C, Cavallini A, Ferrario M, Panzeri C, Castaldo P, Soldovieri MV, Baschirotto C, Bresolin N, Dalla Bernardina B, Taglialatela M, Bassi MT. A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">63</span>:57–65.</span> [<a href="/pubmed/15249611" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15249611</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.brown.1980.673">Brown DA, Adams PR. Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. <span><span class="ref-journal">Nature. </span>1980;<span class="ref-vol">283</span>:673–6.</span> [<a href="/pubmed/6965523" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6965523</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.carvill.2013.825">Carvill GL, Heavin SB, Yendle SC, McMahon JM, O'Roak BJ, Cook J, Khan A, Dorschner MO, Weaver M, Calvert S, Malone S, Wallace G, Stanley T, Bye AM, Bleasel A, Howell KB, Kivity S, Mackay MT, Rodriguez-Casero V, Webster R, Korczyn A, Afawi Z, Zelnick N, Lerman-Sagie T, Lev D, M&#x000f8;ller RS, Gill D, Andrade DM, Freeman JL, Sadleir LG, Shendure J, Berkovic SF, Scheffer IE, Mefford HC. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:825–30.</span> [<a href="/pmc/articles/PMC3704157/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3704157</span></a>] [<a href="/pubmed/23708187" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23708187</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.castaldo.2002.rc199">Castaldo P, del Giudice EM, Coppola G, Pascotto A, Annunziato L, Taglialatela M. Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels. <span><span class="ref-journal">J Neurosci. </span>2002;<span class="ref-vol">22</span>:RC199.</span> [<a href="/pmc/articles/PMC6758678/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6758678</span></a>] [<a href="/pubmed/11784811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11784811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.charlier.1998.53">Charlier C, Singh NA, Ryan SG, Lewis TB, Reus BE, Leach RJ, Leppert M. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. <span><span class="ref-journal">Nature Genet. </span>1998;<span class="ref-vol">18</span>:53–5.</span> [<a href="/pubmed/9425900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9425900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.chen.2003.251">Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J, Huang W. KCNQ1 gain-of-function mutation in familial atrial fibrillation. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">299</span>:251–4.</span> [<a href="/pubmed/12522251" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12522251</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.claes.2004.2155">Claes LR, Ceulemans B, Audenaert D, Deprez L, Jansen A, Hasaerts D, Weckx S, Claeys KG, Del-Favero J, Van Broeckhoven C, De Jonghe P. De novo KCNQ2 mutations in patients with benign neonatal seizures. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">63</span>:2155–8.</span> [<a href="/pubmed/15596769" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15596769</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.concolino.2002.214">Concolino D, Iembo MA, Rossi E, Giglio S, Coppola G, Miraglia Del Giudice E, Strisciuglio P. Familial pericentric inversion of chromosome 5 in a family with benign neonatal convulsions. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:214–6.</span> [<a href="/pmc/articles/PMC1735071/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735071</span></a>] [<a href="/pubmed/11897828" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11897828</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.cooper.2000.4914">Cooper EC, Aldape KD, Abosch A, Barbaro NM, Berger MS, Peacock WS, Jan YN, Jan LY. Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2000;<span class="ref-vol">97</span>:4914–9.</span> [<a href="/pmc/articles/PMC18332/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC18332</span></a>] [<a href="/pubmed/10781098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10781098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.coppola.2003.131">Coppola G, Castaldo P, Miraglia del Giudice E, Bellini G, Galasso F, Soldovieri MV, Anzalone L, Sferro C, Annunziato L, Pascotto A, Taglialatela M. A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">61</span>:131–4.</span> [<a href="/pubmed/12847176" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12847176</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.dalen_meursvan_der_schoor.2014.136">Dalen Meurs-van der Schoor C, van Weissenbruch M, van Kempen M, Bugiani M, Aronica E, Ronner H, Vermeulen RJ. Severe neonatal epileptic encephalopathy and KCNQ2 mutation: neuropathological substrate? <span><span class="ref-journal">Front Pediatr. </span>2014;<span class="ref-vol">2</span>:136.</span> [<a href="/pmc/articles/PMC4271583/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4271583</span></a>] [<a href="/pubmed/25566516" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25566516</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.dedek.2003.21">Dedek K, Fusco L, Teloy N, Steinlein OK. Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2. <span><span class="ref-journal">Epilepsy Res. </span>2003;<span class="ref-vol">54</span>:21–7.</span> [<a href="/pubmed/12742592" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12742592</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.dedek.2001.12272">Dedek K, Kunath B, Kananura C, Reuner U, Jentsch TJ, Steinlein OK. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2001;<span class="ref-vol">98</span>:12272–7.</span> [<a href="/pmc/articles/PMC59804/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC59804</span></a>] [<a href="/pubmed/11572947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11572947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.elghezal.2007.441">Elghezal H, Hannachi H, Mougou S, Kammoun H, Triki C, Saad A. Ring chromosome 20 syndrome without deletions of the subtelomeric and CHRNA4-KCNQ2 genes loci. <span><span class="ref-journal">Eur J Med Genet. </span>2007;<span class="ref-vol">50</span>:441–5.</span> [<a href="/pubmed/17851150" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17851150</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.engel.2001.796">Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. <span><span class="ref-journal">Epilepsia. </span>2001;<span class="ref-vol">42</span>:796–803.</span> [<a href="/pubmed/11422340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11422340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.giardino.2010.146">Giardino D, Vignoli A, Ballarati L, Recalcati MP, Russo S, Camporeale N, Marchi M, Finelli P, Accorsi P, Giordano L, La Briola F, Chiesa V, Canevini MP, Larizza L. Genetic investigations on 8 patients affected by ring 20 chromosome syndrome. <span><span class="ref-journal">BMC Med Genet. </span>2010;<span class="ref-vol">11</span>:146.</span> [<a href="/pmc/articles/PMC2967536/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2967536</span></a>] [<a href="/pubmed/20939888" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20939888</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.grinton.2015.1071">Grinton BE, Heron SE, Pelekanos JT, Zuberi SM, Kivity S, Afawi Z, Williams TC, Casalaz DM, Yendle S, Linder I, Lev D, Lerman-Sagie T, Malone S, Bassan H, Goldberg-Stern H, Stanley T, Hayman M, Calvert S, Korczyn AD, Shevell M, Scheffer IE, Mulley JC, Berkovic SF. Familial neonatal seizures in 36 families: Clinical and genetic features correlate with outcome. <span><span class="ref-journal">Epilepsia. </span>2015;<span class="ref-vol">56</span>:1071–80.</span> [<a href="/pubmed/25982755" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25982755</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.g_rsoy.2016.523">G&#x000fc;rsoy S, Er&#x000e7;al D. Diagnostic approach to genetic causes of early-onset epileptic encephalopathy. <span><span class="ref-journal">J Child Neurol. </span>2016;<span class="ref-vol">31</span>:523–32.</span> [<a href="/pubmed/26271793" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26271793</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.guipponi.1997.473">Guipponi M, Rivier F, Vigevano F, Beck C, Crespel A, Echenne B, Lucchini P, Sebastianelli R, Baldy-Moulinier M, Malafosse A. Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:473–7.</span> [<a href="/pubmed/9147652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9147652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.hardies.2015.3238">Hardies K, de Kovel CG, Weckhuysen S, Asselbergh B, Geuens T, Deconinck T, Azmi A, May P, Brilstra E, Becker F, Barisic N, Craiu D, Braun KP, Lal D, Thiele H, Schubert J, Weber Y, van't Slot R, N&#x000fc;rnberg P, Balling R, Timmerman V, Lerche H, Maudsley S, Helbig I, Suls A, Koeleman BP, De Jonghe P, et al.  Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:3238–50.</span> [<a href="/pubmed/26384929" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26384929</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.heron.2002.851">Heron SE, Crossland KM, Andermann E, Phillips HA, Hall AJ, Bleasel A, Shevell M, Mercho S, Seni MH, Guiot MC, Mulley JC, Berkovic SF, Scheffer IE. Sodium-channel defects in benign familial neonatal-infantile seizures. <span><span class="ref-journal">Lancet. </span>2002;<span class="ref-vol">360</span>:851–2.</span> [<a href="/pubmed/12243921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12243921</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.heron.2007.791">Heron SE, Cox K, Grinton BE, Zuberi SM, Kivity S, Afawi Z, Straussberg R, Berkovic SF, Scheffer IE, Mulley JC. Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures. <span><span class="ref-journal">J Med Genet. </span>2007;<span class="ref-vol">44</span>:791–6.</span> [<a href="/pmc/articles/PMC2652819/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2652819</span></a>] [<a href="/pubmed/17675531" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17675531</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.heron.2012.152">Heron SE, Grinton BE, Kivity S, Afawi Z, Zuberi SM, Hughes JN, Pridmore C, Hodgson BL, Iona X, Sadleir LG, Pelekanos J, Herlenius E, Goldberg-Stern H, Bassan H, Haan E, Korczyn AD, Gardner AE, Corbett MA, G&#x000e9;cz J, Thomas PQ, Mulley JC, Berkovic SF, Scheffer IE, Dibbens LM. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:152–60.</span> [<a href="/pmc/articles/PMC3257886/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3257886</span></a>] [<a href="/pubmed/22243967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22243967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.howell.2015.958">Howell KB, McMahon JM, Carvill GL, Tambunan D, Mackay MT, Rodriguez-Casero V, Webster R, Clark D, Freeman JL, Calvert S, Olson HE, Mandelstam S, Poduri A, Mefford HC, Harvey AS, Scheffer IE. SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">85</span>:958–66.</span> [<a href="/pmc/articles/PMC4567464/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4567464</span></a>] [<a href="/pubmed/26291284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26291284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.inoue.1997.939">Inoue Y, Fujiwara T, Matsuda K, Kubota H, Tanaka M, Yagi K, Yamamori K, Takahashi Y. Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome. <span><span class="ref-journal">Brain. </span>1997;<span class="ref-vol">120</span>:939–53.</span> [<a href="/pubmed/9217679" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9217679</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.international_league_against_epilepsy.1989.389">International League Against Epilepsy.  Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and classification of epilepsies and epileptic syndromes. <span><span class="ref-journal">Epilepsia. </span>1989;<span class="ref-vol">30</span>:389–99.</span> [<a href="/pubmed/2502382" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2502382</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.ishii.2009.27">Ishii A, Fukuma G, Uehara A, Miyajima T, Makita Y, Hamachi A, Yasukochi M, Inoue T, Yasumoto S, Okada M, Kaneko S, Mitsudome A, Hirose S. A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions. <span><span class="ref-journal">Brain Dev. </span>2009;<span class="ref-vol">31</span>:27–33.</span> [<a href="/pubmed/18640800" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18640800</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.ishii.2012.122">Ishii A, Miyajima T, Kurahashi H, Wang JW, Yasumoto S, Kaneko S, Hirose S. KCNQ2 abnormality in BECTS: benign childhood epilepsy with centrotemporal spikes following benign neonatal seizures resulting from a mutation of KCNQ2. <span><span class="ref-journal">Epilepsy Res. </span>2012;<span class="ref-vol">102</span>:122–5.</span> [<a href="/pubmed/22884718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22884718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.kato.2013.1282">Kato M, Yamagata T, Kubota M, Arai H, Yamashita S, Nakagawa T, Fujii T, Sugai K, Imai K, Uster T, Chitayat D, Weiss S, Kashii H, Kusano R, Matsumoto A, Nakamura K, Oyazato Y, Maeno M, Nishiyama K, Kodera H, Nakashima M, Tsurusaki Y, Miyake N, Saito K, Hayasaka K, Matsumoto N, Saitsu H. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation. <span><span class="ref-journal">Epilepsia. </span>2013;<span class="ref-vol">54</span>:1282–7.</span> [<a href="/pubmed/23621294" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23621294</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.klein.2011.1436">Klein KM, Yendle SC, Harvey AS, Antony JH, Wallace G, Bienvenu T, Scheffer IE. A distinctive seizure type in patients with CDKL5 mutations: hypermotor-tonic-spasms sequence. <span><span class="ref-journal">Neurology. </span>2011;<span class="ref-vol">76</span>:1436–8.</span> [<a href="/pubmed/21502606" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21502606</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.kubisch.1999.437">Kubisch C, Schroeder BC, Friedrich T, L&#x000fc;tjohann B, El-Amraoui A, Marlin S, Petit C, Jentsch TJ. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. <span><span class="ref-journal">Cell. </span>1999;<span class="ref-vol">96</span>:437–46.</span> [<a href="/pubmed/10025409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10025409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.kurahashi.2009.1214">Kurahashi H, Wang JW, Ishii A, Kojima T, Wakai S, Kizawa T, Fujimoto Y, Kikkawa K, Yoshimura K, Inoue T, Yasumoto S, Ogawa A, Kaneko S, Hirose S. Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">73</span>:1214–7.</span> [<a href="/pubmed/19822871" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19822871</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.martin.2014.3200">Martin HC, Kim GE, Pagnamenta AT, Murakami Y, Carvill GL, Meyer E, Copley RR, Rimmer A, Barcia G, Fleming MR, Kronengold J, Brown MR, Hudspith KA, Broxholme J, Kanapin A, Cazier JB, Kinoshita T, Nabbout R, Bentley D, McVean G, Heavin S, Zaiwalla Z, McShane T, Mefford HC, Shears D, Stewart H, Kurian MA, Scheffer IE, Blair E, Donnelly P, Kaczmarek LK, Taylor JC, et al.  Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis. <span><span class="ref-journal">Hum Mol Genet. </span>2014;<span class="ref-vol">23</span>:3200–11.</span> [<a href="/pmc/articles/PMC4030775/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4030775</span></a>] [<a href="/pubmed/24463883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24463883</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.mastrangelo.2012.24">Mastrangelo M, Leuzzi V. Genes of early-onset epileptic encephalopathies: from genotype to phenotype. <span><span class="ref-journal">Pediatr Neurol. </span>2012;<span class="ref-vol">46</span>:24–31.</span> [<a href="/pubmed/22196487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22196487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.mastrangelo.2015.119">Mastrangelo M. Novel genes of early-onset epileptic encephalopathies: from genotype to phenotypes. <span><span class="ref-journal">Pediatr Neurol. </span>2015;<span class="ref-vol">53</span>:119–29.</span> [<a href="/pubmed/26073591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26073591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.miceli.2008.65">Miceli F, Soldovieri MV, Martire M, Taglialatela M. Molecular pharmacology and therapeutic potential of neuronal K<sub>v</sub>7-modulating drugs. <span><span class="ref-journal">Curr Opin Pharmacol. </span>2008;<span class="ref-vol">8</span>:65–74.</span> [<a href="/pubmed/18061539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18061539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.miceli.2009.501">Miceli F, Soldovieri MV, Lugli L, Bellini G, Ambrosino P, Migliore M, del Giudice EM, Ferrari F, Pascotto A, Taglialatela M. Neutralization of a unique, negatively-charged residue in the voltage sensor of KV7.2 subunits in a sporadic case of benign familial neonatal seizures. <span><span class="ref-journal">Neurobiol Dis. </span>2009;<span class="ref-vol">34</span>:501–10.</span> [<a href="/pubmed/19344764" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19344764</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.miceli.2013.4386">Miceli F, Soldovieri MV, Ambrosino P, Barrese V, Migliore M, Cilio MR, Taglialatela M. Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of Kv7.2 potassium channel subunits. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2013;<span class="ref-vol">110</span>:4386–91.</span> [<a href="/pmc/articles/PMC3600471/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3600471</span></a>] [<a href="/pubmed/23440208" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23440208</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.miceli.2015.3782">Miceli F, Soldovieri MV, Ambrosino P, De Maria M, Migliore M, Migliore R, Taglialatela M. Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits. <span><span class="ref-journal">J Neurosci. </span>2015;<span class="ref-vol">35</span>:3782–93.</span> [<a href="/pmc/articles/PMC6605567/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6605567</span></a>] [<a href="/pubmed/25740509" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25740509</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.milh.2013.80">Milh M, Boutry-Kryza N, Sutera-Sardo J, Mignot C, Auvin S, Lacoste C, Villeneuve N, Roubertie A, Heron B, Carneiro M, Kaminska A, Altuzarra C, Blanchard G, Ville D, Barthez MA, Heron D, Gras D, Afenjar A, Dorison N, Doummar D, Billette de Villemeur T, An I, Jacquette A, Charles P, Perrier J, Isidor B, Vercueil L, Chabrol B, Badens C, Lesca G, Villard L. Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2013;<span class="ref-vol">8</span>:80.</span> [<a href="/pmc/articles/PMC3670812/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3670812</span></a>] [<a href="/pubmed/23692823" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23692823</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.milh.2015.2314">Milh M, Lacoste C, Cacciagli P, Abidi A, Sutera-Sardo J, Tzelepis I, Colin E, Badens C, Afenjar A, Dieux Coeslier A, Dailland T, Lesca G, Philip N, Villard L. Variable clinical expression in patients with mosaicism for KCNQ2 mutations. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:2314–8.</span> [<a href="/pubmed/25959266" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25959266</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.neubauer.2008.177">Neubauer BA, Waldegger S, Heinzinger J, Hahn A, Kurlemann G, Fiedler B, Eberhard F, Muhle H, Stephani U, Garkisch S, Eeg-Olofsson O, M&#x000fc;ller U, Sander T. KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">71</span>:177–83.</span> [<a href="/pubmed/18625963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18625963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.numis.2014.368">Numis AL, Angriman M, Sullivan JE, Lewis AJ, Striano P, Nabbout R, Cilio MR. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">82</span>:368–70.</span> [<a href="/pmc/articles/PMC3929196/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3929196</span></a>] [<a href="/pubmed/24371303" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24371303</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.okumura.2015.165">Okumura A, Ishii A, Shimojima K, Kurahashi H, Yoshitomi S. lmai K, Imamura M, Seki Y, Toshiaki Shimizu T, Hirose S, Yamamoto T. Phenotypes of children with 20q13.3 microdeletion affecting KCNQ2 and CHRNA4. <span><span class="ref-journal">Epileptic Disord. </span>2015;<span class="ref-vol">17</span>:165–71.</span> [<a href="/pubmed/26030193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26030193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.orhan.2014.382">Orhan G, Bock M, Schepers D, Ilina EI, Reichel SN, L&#x000f6;ffler H, Jezutkovic N, Weckhuysen S, Mandelstam S, Suls A, Danker T, Guenther E, Scheffer IE, De Jonghe P, Lerche H, Maljevic S. Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy. <span><span class="ref-journal">Ann Neurol. </span>2014;<span class="ref-vol">75</span>:382–94.</span> [<a href="/pubmed/24318194" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24318194</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.painter.1981.1107">Painter MJ, Pippenger C, Wasterlain C, Barmada M, Pitlick W, Carter G, Abern S. Phenobarbital and phenytoin in neonatal seizures: metabolism and tissue distribution. <span><span class="ref-journal">Neurology. </span>1981;<span class="ref-vol">31</span>:1107–12.</span> [<a href="/pubmed/7196530" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7196530</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.pascual.2013.35">Pascual FT, Wierenga KJ, Ng YT. Contiguous deletion of KCNQ2 and CHRNA4 may cause a different disorder from benign familial neonatal seizures. <span><span class="ref-journal">Epilepsy Behav Case Rep. </span>2013;<span class="ref-vol">1</span>:35–8.</span> [<a href="/pmc/articles/PMC4150641/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4150641</span></a>] [<a href="/pubmed/25667822" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25667822</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.pavone.2012.459">Pavone P, Spalice A, Polizzi A, Parisi P, Ruggieri M. Ohtahara syndrome with emphasis on recent genetic discovery. <span><span class="ref-journal">Brain Dev. </span>2012;<span class="ref-vol">34</span>:459–68.</span> [<a href="/pubmed/21967765" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21967765</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.pisano.2015.685">Pisano T, Numis AL, Heavin SB, Weckhuysen S, Angriman M, Suls A, Podesta B, Thibert RL, Shapiro KA, Guerrini R, Scheffer IE, Marini C, Cilio MR. Early and effective treatment of KCNQ2 encephalopathy. <span><span class="ref-journal">Epilepsia. </span>2015;<span class="ref-vol">56</span>:685–91.</span> [<a href="/pubmed/25880994" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25880994</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.plouin.2012">Plouin P, Neubauer BA. Benign familial and non-familial neonatal seizures. In: Bureau M, Genton P, Dravet C, Delgado-Escueta A, Tassinari CA, Thomas P, Wolf P, eds. <em>Epileptic Syndromes in Infancy, Childhood and Adolescence</em>. 5 ed. Montrouge, France: John Libbey Eurotext Ltd. 2012:77-88.</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.porter.2012.103">Porter RJ, Burdette DE, Gil-Nagel A, Hall ST, White R, Shaikh S, DeRossett SE. Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials. <span><span class="ref-journal">Epilepsy Res. </span>2012;<span class="ref-vol">101</span>:103–12.</span> [<a href="/pubmed/22512894" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22512894</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.reid.2016.79">Reid ES, Williams H, Stabej Ple Q, James C, Ocaka L, Bacchelli C, Footitt EJ, Boyd S, Cleary MA, Mills PB, Clayton PT. Seizures due to a KCNQ2 mutation: treatment with nitamin B6. <span><span class="ref-journal">JIMD Rep. </span>2016;<span class="ref-vol">27</span>:79–84.</span> [<a href="/pmc/articles/PMC5580730/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5580730</span></a>] [<a href="/pubmed/26446091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26446091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.rett.1964.609">Rett A, Teubel R. Neugeborenen Krampfe im Rahmen einer epileptisch belasten Familie. <span><span class="ref-journal">Wiener Klinische Wochenschrift. </span>1964;<span class="ref-vol">76</span>:609–13.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.ronen.1993.1355">Ronen GM, Rosales TO, Connolly M, Anderson VE, Leppert M. Seizure characteristics in chromosome 20 benign familial neonatal convulsions. <span><span class="ref-journal">Neurology. </span>1993;<span class="ref-vol">43</span>:1355–60.</span> [<a href="/pubmed/8327138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8327138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.sadewa.2008.167">Sadewa AH, Sasongko TH, Gunadi N, Lee MJ, Daikoku K, Yamamoto A, Yamasaki T, Tanaka S, Matsuo M, Nishio H. Germ-line mutation of KCNQ2, p.R213W, in a Japanese family with benign familial neonatal convulsion. <span><span class="ref-journal">Pediatr Int. </span>2008;<span class="ref-vol">50</span>:167–71.</span> [<a href="/pubmed/18353052" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18353052</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.saitsu.2012.298">Saitsu H, Kato M, Koide A, Goto T, Fujita T, Nishiyama K, Tsurusaki Y, Doi H, Miyake N, Hayasaka K, Matsumoto N. Whole exome sequencing identifies KCNQ2 mutations in Ohtahara syndrome. <span><span class="ref-journal">Ann Neurol. </span>2012;<span class="ref-vol">72</span>:298–300.</span> [<a href="/pubmed/22926866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22926866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.schmitt.2005.161">Schmitt B, Wohlrab G, Sander T, Steinlein OK, Hajnal BL. Neonatal seizures with tonic clonic sequences and poor developmental outcome. <span><span class="ref-journal">Epilepsy Res. </span>2005;<span class="ref-vol">65</span>:161–8.</span> [<a href="/pubmed/16039833" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16039833</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.schroeder.1998.687">Schroeder BC, Kubisch C, Stein V, Jentsch TJ. Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. <span><span class="ref-journal">Nature. </span>1998;<span class="ref-vol">396</span>:687–90.</span> [<a href="/pubmed/9872318" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9872318</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.serino.2013.158">Serino D, Specchio N, Pontrelli G, Vigevano F, Fusco L. Video/EEG findings in a KCNQ2 epileptic encephalopathy: a case report and revision of literature data. <span><span class="ref-journal">Epileptic Disord. </span>2013;<span class="ref-vol">15</span>:158–65.</span> [<a href="/pubmed/23774309" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23774309</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.singh.1998.25">Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, Ronen GM, Bjerre I, Quattlebaum T, Murphy JV, McHarg ML, Gagnon D, Rosales TO, Peiffer A, Anderson VE, Leppert M. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. <span><span class="ref-journal">Nature Genet. </span>1998;<span class="ref-vol">18</span>:25–9.</span> [<a href="/pubmed/9425895" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9425895</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.singh.2003.2726">Singh NA, Westenskow P, Charlier C, Pappas C, Leslie J, Dillon J, Anderson VE, Sanguinetti MC, et al.  KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. <span><span class="ref-journal">Brain. </span>2003;<span class="ref-vol">126</span>:2726–37.</span> [<a href="/pubmed/14534157" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14534157</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.soldovieri.2006.418">Soldovieri MV, Castaldo P, Iodice L, Miceli F, Barrese V, Bellini G, Miraglia del Giudice E, Pascotto A, Bonatti S, Annunziato L, Taglialatela M. Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions. <span><span class="ref-journal">J Biol Chem. </span>2006;<span class="ref-vol">281</span>:418–28.</span> [<a href="/pubmed/16260777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16260777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.soldovieri.2011.365">Soldovieri MV, Miceli F, Taglialatela M. Driving with no brakes: molecular pathophysiology of Kv7 potassium channels. <span><span class="ref-journal">Physiology (Bethesda). </span>2011;<span class="ref-vol">26</span>:365–76.</span> [<a href="/pubmed/22013194" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22013194</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.soldovieri.2014.356">Soldovieri MV, Boutry-Kryza N, Milh M, Doummar D, Heron B, Bourel E, Ambrosino P, Miceli F, De Maria M, Dorison N, Auvin S, Echenne B, Oertel J, Riquet A, Lambert L, Gerard M, Roubergue A, Calender A, Mignot C, Taglialatela M, Lesca G. Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A. <span><span class="ref-journal">Hum Mutat. </span>2014;<span class="ref-vol">35</span>:356–67.</span> [<a href="/pubmed/24375629" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24375629</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.steinlein.2007.245">Steinlein OK, Conrad C, Weidner B. Benign familial neonatal convulsions: always benign? <span><span class="ref-journal">Epilepsy Res. </span>2007;<span class="ref-vol">73</span>:245–9.</span> [<a href="/pubmed/17129708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17129708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.striano.2006.218">Striano P, Bordo L, Lispi ML, Specchio N, Minetti C, Vigevano F, Zara F. A novel SCN2A mutation in family with benign familial infantile seizures. <span><span class="ref-journal">Epilepsia. </span>2006;<span class="ref-vol">47</span>:218–20.</span> [<a href="/pubmed/16417554" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16417554</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.traylor.2010.e12462">Traylor RN, Bruno DL, Burgess T, Wildin R, Spencer A, Ganesamoorthy D, Amor DJ, Hunter M, Caplan M, Rosenfeld JA, Theisen A, Torchia BS, Shaffer LG, Ballif BC, Slater HR. A genotype-first approach for the molecular and clinical characterization of uncommon de novo microdeletion of 20q13.33. <span><span class="ref-journal">PLoS One. </span>2010;<span class="ref-vol">5</span>:e12462.</span> [<a href="/pmc/articles/PMC2929201/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2929201</span></a>] [<a href="/pubmed/20805988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20805988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.tulloch.2012.31">Tulloch JK, Carr RR, Ensom MH. A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures. <span><span class="ref-journal">J Pediatr Pharmacol Ther. </span>2012;<span class="ref-vol">17</span>:31–44.</span> [<a href="/pmc/articles/PMC3428186/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3428186</span></a>] [<a href="/pubmed/23118657" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23118657</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.wang.1998.1890">Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS, Dixon JE, McKinnon D. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. <span><span class="ref-journal">Science. </span>1998;<span class="ref-vol">282</span>:1890–3.</span> [<a href="/pubmed/9836639" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9836639</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.wang.1996.17">Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Toubin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. <span><span class="ref-journal">Nat. Genet. </span>1996;<span class="ref-vol">12</span>:17–23.</span> [<a href="/pubmed/8528244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8528244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.weckhuysen.2012.15">Weckhuysen S, Mandelstam S, Suls A, Audenaert D, Deconinck T, Claes LR, Deprez L, Smets K, Hristova D, Yordanova I, Jordanova A, Ceulemans B, Jansen A, Hasaerts D, Roelens F, Lagae L, Yendle S, Stanley T, Heron SE, Mulley JC, Berkovic SF, Scheffer IE, de Jonghe P. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. <span><span class="ref-journal">Ann Neurol. </span>2012;<span class="ref-vol">71</span>:15–25.</span> [<a href="/pubmed/22275249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22275249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.weckhuysen.2013.1697">Weckhuysen S, Ivanovic V, Hendrickx R, Van Coster R, Hjalgrim H, M&#x000f8;ller RS, Gr&#x000f8;nborg S, Schoonjans AS, Ceulemans B, Heavin SB, Eltze C, Horvath R, Casara G, Pisano T, Giordano L, Rostasy K, Haberlandt E, Albrecht B, Bevot A, Benkel I, Syrbe S, Sheidley B, Guerrini R, Poduri A, Lemke JR, Mandelstam S, Scheffer I, Angriman M, Striano P, Marini C, Suls A, De Jonghe P, et al.  Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">81</span>:1697–703.</span> [<a href="/pmc/articles/PMC3812107/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3812107</span></a>] [<a href="/pubmed/24107868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24107868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.wuttke.2007.2045">Wuttke TV, Jurkat-Rott K, Paulus W, Garncarek M, Lehmann-Horn F, Lerche H. Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">69</span>:2045–53.</span> [<a href="/pubmed/17872363" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17872363</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.zara.2013.425">Zara F, Specchio N, Striano P, Robbiano A, Gennaro E, Paravidino R, Vanni N, Beccaria F, Capovilla G, Bianchi A, Caffi L, Cardilli V, Darra F, Bernardina BD, Fusco L, Gaggero R, Giordano L, Guerrini R, Incorpora G, Mastrangelo M, Spaccini L, Laverda AM, Vecchi M, Vanadia F, Veggiotti P, Viri M, Occhi G, Budetta M, Taglialatela M, Coviello DA, Vigevano F, Minetti C. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance. <span><span class="ref-journal">Epilepsia. </span>2013;<span class="ref-vol">54</span>:425–36.</span> [<a href="/pubmed/23360469" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23360469</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.zhou.2006.691">Zhou X, Ma A, Liu X, Huang C, Zhang Y, Shi R, Mao S, Geng T, Li S. Infantile seizures and other epileptic phenotypes in a Chinese family with a missense mutation of KCNQ2. <span><span class="ref-journal">Eur J Pediatr. </span>2006;<span class="ref-vol">165</span>:691–5.</span> [<a href="/pubmed/16691402" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16691402</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bfns.REF.zou.2006.1696">Zou YS, Van Dyke DL, Thorland EC, Chhabra HS, Michels VV, Keefe JG, Lega MA, Feely MA, Uphoff TS, Jalal SM. Mosaic ring 20 with no detectable deletion by FISH analysis: characteristic seizure disorder and literature review. <span><span class="ref-journal">Am J Med Genet. </span>2006;<span class="ref-vol">140</span>:1696–706.</span> [<a href="/pubmed/16835934" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16835934</span></a>]</div></li></ul></div></div><div id="bfns.Chapter_Notes"><h2 id="_bfns_Chapter_Notes_">Chapter Notes</h2><div id="bfns.Acknowledgments"><h3>Acknowledgments</h3><p>MT acknowledges Telethon (GGP15113) for supporting studies in his lab throughout the years. FM and MVS are supported by postdoctoral fellowships from the Fondazione Umberto Veronesi and the Italian Society or Pharmacology, respectively. NJ and ECC are supported by NIH NS49119, CURE, and the Jack Pribaz Foundation. SW is supported by the French program "Investissements d'avenir" (ANR-10-IAIHU-06). The collaboration of patients and their families is also highly appreciated.</p></div><div id="bfns.Author_History"><h3>Author History</h3><p>Giulia Bellini, PhD; Second University of Naples (2009-2016)<br />Edward Cooper, MD, PhD (2016-present)<br />Giangennaro Coppola, MD; University of Salerno (2013-2016)<br />Nishtha Joshi, PhD (2016-present)<br />Francesco Miceli, PhD (2009-present)<br />Emanuele Miraglia del Giudice, MD; Second University of Naples (2009-2016)<br />Antonio Pascotto, MD; Second University of Naples (2009-2013)<br />Maria Virginia Soldovieri, PhD (2009-present)<br />Maurizio Taglialatela, MD, PhD (2005-present)<br />Sarah Weckhuysen, MD, PhD (2016-present)</p></div><div id="bfns.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>27 September 2018 (aa) Revision: removed linkaway Table 4</div></li><li class="half_rhythm"><div>31 March 2016 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 April 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>4 August 2011 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically for <i>KCNQ2</i> and <i>KCNQ3</i></div></li><li class="half_rhythm"><div>27 April 2010 (me) Review posted live</div></li><li class="half_rhythm"><div>4 December 2009 (mt) Initial submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK32534</span><span class="label">PMID: <a href="/pubmed/20437616" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20437616</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kcnk9-is/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kcnq3-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK32534&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK32534/?report=reader">PubReader</a></li><li><a href="/books/NBK32534/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK32534" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK32534" style="display:none" title="Cite this Page"><div class="bk_tt">Miceli F, Soldovieri MV, Joshi N, et al. KCNQ2-Related Disorders. 2010 Apr 27 [Updated 2018 Sep 27]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK32534/pdf/Bookshelf_NBK32534.pdf">PDF version of this page</a> (532K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#bfns.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#bfns.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#bfns.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#bfns.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#bfns.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#bfns.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#bfns.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#bfns.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#bfns.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#bfns.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#bfns.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#bfns.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3785[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNQ2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK32534+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1990836" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1990836" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1990836" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1990836" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24851285" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNQ3</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNQ3</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Miceli F, Soldovieri MV, Joshi N, Weckhuysen S, Cooper EC, Taglialatela M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30234941" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gertler T, Bearden D, Bhattacharjee A, Carvill G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25880994" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Early and effective treatment of KCNQ2 encephalopathy.</a><span class="source">[Epilepsia. 2015]</span><div class="brieflinkpop offscreen_noflow">Early and effective treatment of KCNQ2 encephalopathy.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pisano T, Numis AL, Heavin SB, Weckhuysen S, Angriman M, Suls A, Podesta B, Thibert RL, Shapiro KA, Guerrini R, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Epilepsia. 2015 May; 56(5):685-91. Epub 2015 Apr 16.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301494" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Miller IO, Sotero de Menezes MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27683935" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRIN2A</i>-Related Speech Disorders and Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRIN2A</i>-Related Speech Disorders and Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Myers KA, Scheffer IE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20437616" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20437616" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0415d075f66d18aa521d58">KCNQ2-Related Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">KCNQ2-Related Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:07:12-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CDCE0E040237100000000082502D2&amp;ncbi_session=CE8CDCE0E0415CF1_2085SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK32534%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK32534&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK32534/&amp;ncbi_pagename=KCNQ2-Related Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CDCE0E0415CF1_2085SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>